Other intervertebral disc disorders

M13_INTERVERTEB

lumbar disc degeneration: Any disease of a degenerative nature that affects the intervertebral disc.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M51 Hospital discharge: ICD-9 — 722 Hospital discharge: ICD-8 — 725 Hospital discharge: excluded ICD-9 — 7220\|7224\|7227\|7228A Hospital discharge: excluded ICD-8 — 7250 Cause of death: ICD-10 — M51 Cause of death: ICD-9 — 722 Cause of death: ICD-8 — 725 Cause of death: excluded ICD-9 — 7220\|7224\|7227\|7228A Cause of death: excluded ICD-8 — 7250 2 out of 7 registries used, show all original rules.	60592
4. Check minimum number of events None	60592
5. Include endpoints None	60592
6. Filter based on genotype QC (FinnGen only)	54877

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M50-M54
Name in latin: Aliae morbositates discorum intervertebralium

NAME	M13_INTERVERTEB
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M51
HD_ICD_9	722
HD_ICD_8	725
HD_ICD_10_EXCL
HD_ICD_9_EXCL	7220\|7224\|7227\|7228A
HD_ICD_8_EXCL	7250
COD_MAINONLY
COD_ICD_10	M51
COD_ICD_9	722
COD_ICD_8	725
COD_ICD_10_EXCL
COD_ICD_9_EXCL	7220\|7224\|7227\|7228A
COD_ICD_8_EXCL	7250
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other intervertebral disc disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	361216	182083	177156
Only index persons	337293	173994	163299
Unadjusted period prevalence (%)
Whole population	5.07	5.22	4.95
Only index persons	6.32	6.40	6.23
Median age at first event (years)
Whole population	48.22	49.60	46.80
Only index persons	47.83	49.27	46.30

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	54877	31257	23620
Unadjusted period prevalence (%)	10.98	11.10	10.83
Median age at first event (years)	49.85	49.26	50.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
52940: Matched controls
315459

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

322.8

18662

85535

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.5

322.7

1346

2344

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.4

322.2

673

629

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

321.4

6218

21942

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

321.1

2280

5442

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.4

320.0

1390

2489

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

319.0

1459

2704

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

318.1

377

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

317.1

2667

6905

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

460.5

313.5

384

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.9

313.3

1731

3605

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.3

312.7

2732

7196

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.3

312.6

2893

7816

L14

ICPC

Leg/thigh symptom/complaint

2.1

311.6

3723

11160

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

311.5

17127

77595

M50.8

ICD-10 Finland

Other cervical disc disorders

40.4

311.4

290

N01

ICPC

Headache

1.9

309.1

4858

16046

C01DA14

ATC

isosorbide mononitrate; oral

1.8

308.1

6144

21858

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

307.7

5617

19458

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

19610

82221

G44.2

ICD-10 Finland

Tension-type headache

2.6

307.7

7606

19159

N03AX09

ATC

lamotrigine; oral

2.6

307.7

2388

5703

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

307.7

18324

82761

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

23874

96363

M54.4

ICD-10 Finland

Lumbago with sciatica

13.7

307.7

20691

14084

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

9.4

307.7

753

486

N02AC04

ATC

dextropropoxyphene; oral

4.8

307.7

1968

2537

N03AX12

ATC

[U] gabapentin; oral

10.0

307.7

15938

13063

J01AA02

ATC

doxycycline; systemic

2.1

307.7

40671

193561

R4110, ,

SPAT

2.3

307.7

6872

19154

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

307.7

10961

39626

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.1

307.7

2172

1884

N06AX21

ATC

duloxetine; oral

5.3

307.7

9517

12564

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

9335

33200

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

20.9

307.7

743

215

R52.1

ICD-10 Finland

Chronic intractable pain

17.1

307.7

799

283

WX720

NOMESCO Finland

Own respiration

2.5

307.7

2552

6319

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

934.8

307.7

610

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.2

307.7

1200

1727

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

45.3

307.7

310

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

38.7

307.7

310

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

307.7

5630

17126

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.3

307.7

1756

3221

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

307.7

4073

11796

R01AD58

ATC

fluticasone, combinations; nasal

1.6

307.7

12155

49366

R05

ICD-10 Finland

Cough

1.6

307.7

9871

38828

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.6

307.7

1007

1335

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

436.6

307.7

1975

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

277.2

307.7

1004

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

307.7

438

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

20759

92096

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

307.7

36456

178822

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

307.7

5214

15923

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

307.7

20510

90107

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.4

307.7

4334

11422

WX290

NOMESCO Finland

Other blockage of nerve

1.4

307.7

22932

108900

M43.1

ICD-10 Finland

Spondylolisthesis

37.8

307.7

3305

554

L29

ICPC

Musculoskeletal sympt/complt other

2.1

307.7

4151

12230

ACC51

NOMESCO Finland

Release of median nerve

2.7

307.7

3998

9105

A02BC05

ATC

esomeprazole; systemic

2.2

307.7

22351

78310

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

307.7

940

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

13.0

307.7

1817

857

M01AE02

ATC

naproxen; oral, rectal

2.1

307.7

30080

122978

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

86.9

307.7

534

N06AA10

ATC

nortriptyline; systemic

6.0

307.7

1348

1358

D01

ICPC

Abdominal pain/cramps general

1.9

307.7

5646

18999

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.5

307.7

1797

3123

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

33334

164464

A11

ICPC

Chest pain NOS

2.1

307.7

3885

11441

J01FA09

ATC

clarithromycin; systemic

1.6

307.7

14780

60124

A02BC02

ATC

pantoprazole; systemic

2.5

307.7

37639

157222

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.2

307.7

5447

15585

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.9

307.7

3602

7879

M54.5

ICD-10 Finland

Low back pain

6.1

307.7

28280

50132

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

307.7

10021

39838

G47.3

ICD-10 Finland

Sleep apnoea

1.9

307.7

11862

41926

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

257.3

307.7

808

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

307.7

14599

60927

L02

ICPC

Back symptom/complaint

2.6

307.7

5683

13818

R96

ICPC

Asthma

2.1

307.7

4720

13764

C10AX09

ATC

ezetimibe; oral

1.9

307.7

7939

27160

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

8.8

307.7

1081

743

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

307.7

13215

45186

R01AD08

ATC

fluticasone; nasal

1.5

307.7

13290

56368

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

307.7

9915

36257

A02BC01

ATC

omeprazole; systemic

2.0

307.7

13843

47405

N05AH04

ATC

quetiapine; oral

1.8

307.7

8461

30773

L13

ICPC

Hip symptom/complaint

2.4

307.7

10263

28696

WX704

NOMESCO Finland

Intubation

2.6

307.7

4796

11722

A01

ICPC

Pain general/multiple sites

3.2

307.7

5970

11901

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

307.7

11136

32289

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

307.7

5490

18577

L03

ICPC

Low back symptom/complaint

4.2

307.7

21385

43496

J02AC01

ATC

fluconazole; systemic

1.6

307.7

18854

80790

N06AA09

ATC

amitriptyline; systemic

4.9

307.7

6513

8752

L01

ICPC

Neck symptom/complaint

2.3

307.7

8688

24543

M03BX02

ATC

tizanidine; oral

3.8

307.7

38907

133486

M01AH03

ATC

valdecoxib; oral

3.0

307.7

3206

6614

L15

ICPC

Knee symptom/complaint

1.8

307.7

12384

44777

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

65.2

307.7

294

M54

ICD-10 Finland

Dorsalgia

2.9

307.7

7757

17384

K30

ICD-10 Finland

Functional dyspepsia

2.1

307.7

5713

16837

R02

ICPC

Shortness of breath/dyspnoea

2.1

307.7

6802

20469

R03BA05

ATC

fluticasone; inhalant

1.7

307.7

8241

31230

NA3BG, ,

SPAT

5.2

307.7

3076

3724

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

307.7

3422

9314

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

307.7

17888

79795

UKC02

NOMESCO Finland

Cystoscopy

1.8

307.7

7061

24533

M79.7

ICD-10 Finland

Fibromyalgia

6.0

307.7

2301

2367

R01AD09

ATC

mometasone; nasal

1.7

307.7

22798

99059

M51

ICD-10 Finland

Other intervertebral disc disorders

12.6

307.7

548

261

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.4

307.7

3042

7762

M43.0

ICD-10 Finland

Spondylolysis

59.4

307.7

1303

134

R05

ICPC

Cough

1.7

307.7

11863

46113

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

257.6

307.7

35517

2477

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

307.7

526

A06AD11

ATC

lactulose; oral

1.8

307.7

6303

21555

M54.1

ICD-10 Finland

Radiculopathy

21.0

307.7

3905

1194

M54.2

ICD-10 Finland

Cervicalgia

5.3

307.7

5184

6329

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

111.0

307.7

1148

N02AA05

ATC

oxycodone; systemic

2.3

307.7

9395

26622

WX308

NOMESCO Finland

Sacral anesthesy

92.9

307.7

387

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

307.7

12755

39188

N05CF01

ATC

zopiclone; oral

1.8

307.7

15872

59841

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

14100

46488

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

307.7

14378

59277

N02BF02

ATC

pregabalin; oral

5.4

307.7

4989

5961

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

307.7

20621

85875

S18

ICPC

Laceration/cut

2.0

307.7

24664

97104

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

307.7

12187

42067

M01AX17

ATC

nimesulide; oral

2.5

307.7

12743

35987

H02AB06

ATC

prednisolone; systemic

2.0

307.7

25347

98659

AA1AD

NOMESCO Finland

CT of head and brain

1.9

307.7

14056

50477

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

307.7

5849

20078

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

307.7

9462

32769

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

307.7

8452

30722

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

307.7

16417

72397

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.1

307.7

3483

6905

N03AX16

ATC

[U] pregabalin

8.1

307.7

21162

23998

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

307.7

3758

8805

R06AE07

ATC

cetirizine; oral

1.5

307.7

21026

95223

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

55.8

307.7

702

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

307.7

5432

18012

SPAT1260

SPAT

Consultation of another employee

1.8

307.7

7906

28515

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.1

307.7

5850

12253

SPAT1229

SPAT

Assessment of need for aid

2.3

307.7

3206

8739

G54.0

ICD-10 Finland

Brachial plexus disorders

5.9

307.7

1585

1631

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.1

307.7

5926

17762

M48.0

ICD-10 Finland

Spinal stenosis

76.6

307.7

12856

1316

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.9

307.7

1406

1735

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

307.7

15370

44385

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

18390

82591

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

28110

127431

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

144.3

307.7

265

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

307.7

25677

118724

M25.5

ICD-10 Finland

Pain in joint

2.5

307.7

19355

59982

R07.3

ICD-10 Finland

Other chest pain

2.3

307.7

5116

14158

TAB20

NOMESCO Finland

Epidural puncture

22.7

307.7

789

210

C10AA05

ATC

atorvastatin; oral

1.6

307.7

19407

83895

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

307.7

15303

50186

L08

ICPC

Shoulder symptom/complaint

2.1

307.7

12306

39748

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

307.7

8113

22996

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

307.7

4678

10151

L84

ICPC

Back syndrome without radiat pain

3.7

307.7

2657

4494

R03BA01

ATC

beclometasone; inhalant

1.8

307.7

6353

21954

R4110

NOMESCO Finland

Physiotherapy

1.7

307.7

13221

51093

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

307.7

9631

30750

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

29316

139941

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.0

307.7

1183

1206

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

307.7

2567

M01AB55

ATC

diclofenac, combinations; oral

3.4

307.7

3443

6332

SPAT1216

SPAT

Assessment of functional ability

1.8

307.7

6396

22302

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

27604

127833

N02BE01

ATC

paracetamol; systemic, rectal

3.8

307.7

48659

236546

M02AA07

ATC

piroxicam; topical

1.9

307.7

17574

64787

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

307.7

6063

20734

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

307.7

478

35399

ICD-8 Finland

Sciatica

9.1

307.7

557

367

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.8

307.7

1878

2414

Z3226

NOMESCO Finland

Physiotherapist

2.0

307.7

8729

28084

ZXA05

NOMESCO Finland

Left side

1.7

307.7

10968

41177

M01AC06

ATC

meloxicam; systemic, rectal

2.5

307.7

20307

63007

D07AC01

ATC

betamethasone; topical

1.5

307.7

17027

76043

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

307.7

15783

41273

A02BA02

ATC

ranitidine; systemic

2.2

307.7

9343

28515

G04BD12

ATC

mirabegron; oral

2.0

307.7

5210

16582

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

29124

121415

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

307.7

3074

8187

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

318.7

307.7

478

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

307.7

11258

46069

N02AJ13

ATC

tramadol and paracetamol; systemic

6.1

307.7

1457

1466

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

307.7

12920

54695

M76.6

ICD-10 Finland

Achilles tendinitis

2.8

307.7

2065

4464

J01FA10

ATC

azithromycin; systemic

1.6

307.7

28321

130674

SPAT1301

SPAT

No procedures

1.7

307.7

14674

57743

C07AA05

ATC

propranolol; systemic

1.7

307.7

9191

35528

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

12090

47733

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

307.7

3468

8168

N06AX11

ATC

mirtazapine; oral

2.0

307.7

18443

66029

M50.3

ICD-10 Finland

Other cervical disc degeneration

29.7

307.7

1890

393

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

307.7

4350

13616

NA3AA, ,

SPAT

2.9

307.7

1915

3977

G04CA02

ATC

tamsulosin; oral

1.6

307.7

10049

40193

Z50.1

ICD-10 Finland

Other physical therapy

3.0

307.7

2630

5478

N05BA01

ATC

diazepam; systemic, rectal

2.2

307.7

6279

18524

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

307.7

892

M48.9

ICD-10 Finland

Spondylopathy, unspecified

62.0

307.7

372

J01MA02

ATC

ciprofloxacin; systemic

1.7

307.7

18878

78495

H02AB04

ATC

methylprednisolone; systemic

1.8

307.7

6469

22451

N05BA04

ATC

oxazepam; oral

1.7

307.7

12364

48665

M45

ICD-10 Finland

Ankylosing spondylitis

35.7

307.7

821

139

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

307.7

6144

19992

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

11635

38700

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

17574

79359

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

307.7

16400

68095

J01DB01

ATC

cefalexin; oral

2.0

307.7

42919

216688

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

19.1

307.7

1027

327

M53.2

ICD-10 Finland

Spinal instabilities

104.1

307.7

707

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

307.7

3486

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.4

307.7

3117

7972

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

41012

214485

XA402

NOMESCO Finland

ENMG

7.1

307.7

1672

1433

M01AB05

ATC

diclofenac; systemic, rectal

2.8

307.7

38100

149607

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

307.7

8554

28501

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

19.1

307.7

503

158

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

8.0

307.7

2200

1707

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

113.7

307.7

360

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

307.7

11171

42484

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

307.7

9024

33698

C07AB07

ATC

bisoprolol; oral

1.7

307.7

22830

98215

N03AE01

ATC

clonazepam; systemic

3.2

307.7

3000

5893

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

307.7

14295

56323

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.8

307.7

3026

6657

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

307.7

4901

13785

A03FA02

ATC

cisapride; oral, rectal

2.2

307.7

3153

8653

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

8.8

307.7

852

587

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.0

307.7

10420

12361

M03BC51

ATC

orphenadrine, combinations; systemic

2.5

307.7

15690

45930

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.0

307.7

5509

11717

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2249.4

307.7

2209

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

80.3

307.7

6357

535

R52.2

ICD-10 Finland

Other chronic pain

5.9

307.7

2565

2720

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

13717

56318

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

307.7

9515

28824

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

111.3

307.7

426

M01AC01

ATC

piroxicam; systemic, rectal

2.1

307.7

6039

18579

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.7

307.7

1196

1543

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

307.7

4235

12810

C10AA01

ATC

simvastatin; oral

1.5

307.7

17485

78136

M01AH02

ATC

rofecoxib; oral

3.0

307.7

6905

15121

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

307.7

4781

14008

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

20234

71375

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

282.2

307.7

793

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

99.5

307.7

5976

403

9211

FHL

Exploration or removal of diskusprolapse

709.2

307.7

2059

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

307.7

4685

13882

J01DA01

ATC

[U] cefalexin

1.6

307.7

30651

144234

M01AH01

ATC

celecoxib; oral

3.0

307.7

10580

24108

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

307.7

15380

47800

L16

ICPC

Ankle symptom/complaint

1.9

307.7

5377

18038

R5599

NOMESCO Finland

Other rehabilitation service

4.4

307.7

1390

1910

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

307.7

3069

7412

M35.7

ICD-10 Finland

Hypermobility syndrome

6.5

307.7

796

744

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

267.3

307.7

6007

151

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

17.1

307.7

464

163

N02AX02

ATC

tramadol; systemic, rectal

5.2

307.7

32125

72115

R03BA02

ATC

budesonide; inhalant

1.7

307.7

8151

30743

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.4

307.7

2034

2298

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

131.3

307.7

1851

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

307.7

4445

12310

R03DC03

ATC

montelukast; oral

1.9

307.7

8011

27002

M70.6

ICD-10 Finland

Trochanteric bursitis

3.6

307.7

8185

15336

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

29.3

307.7

656

135

R52.9

ICD-10 Finland

Pain, unspecified

2.5

307.7

5572

14302

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

307.7

387

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

160.2

307.7

506

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

13.2

307.7

2170

1018

UJF32

NOMESCO Finland

Coloscopy

2.0

307.7

13201

44487

M79.6

ICD-10 Finland

Pain in limb

2.6

307.7

26027

85558

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

307.7

4878

13933

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

307.7

12607

53173

M01AB51

ATC

indometacin, combinations; oral, rectal

4.4

307.7

1264

1740

M01AX01

ATC

nabumetone; oral

3.8

307.7

2193

3591

N04BC05

ATC

pramipexole; oral

2.7

307.7

3658

8579

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

14266

59226

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.6

307.7

2674

6384

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

97.6

307.7

2274

145

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

53.7

307.7

991

112

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

307.7

3991

11587

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

822.1

307.7

2246

J01FA06

ATC

roxithromycin; oral

1.7

307.7

19305

79911

M47.9

ICD-10 Finland

Spondylosis, unspecified

47.1

307.7

2832

378

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.1

307.7

2654

4055

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

260.4

307.7

3586

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

15.8

307.7

440

167

M01AH05

ATC

etoricoxib; oral

3.1

307.7

37211

136865

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

41.2

307.7

4651

736

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.7

307.7

7527

13398

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

307.7

13250

45148

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

4.9

307.7

951

1177

M54.3

ICD-10 Finland

Sciatica

15.4

307.7

6136

2663

C10AA07

ATC

rosuvastatin; oral

1.7

307.7

16266

65570

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.5

307.7

4032

7177

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

307.7

2791

7023

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

14259

58390

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

307.7

4590

10620

R20.2

ICD-10 Finland

Paraesthesia of skin

2.6

307.7

3731

9061

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

307.7

23475

101506

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

307.7

3467

9036

N02AJ06

ATC

codeine and paracetamol; systemic

3.0

307.7

26952

81408

A02BC03

ATC

lansoprazole; oral

2.5

307.7

16171

47407

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

98.6

307.7

17468

1568

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

307.7

6454

20485

M79.1

ICD-10 Finland

Myalgia

2.3

307.7

7995

22507

X58

ICD-10 Finland

Exposure to other specified factors

1.9

307.7

7235

24863

L12

ICPC

Hand/finger symptom/complaint

1.9

307.7

8499

28996

SPAT1097

SPAT

Recording of ECG

1.8

307.7

6142

21477

M54.9

ICD-10 Finland

Dorsalgia, unspecified

6.7

307.7

9541

10073

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.6

307.7

1107

1467

A02BC04

ATC

rabeprazole; oral

2.1

307.7

4170

12084

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.2

307.7

1393

645

M01AE01

ATC

ibuprofen; systemic, rectal

2.5

307.7

47646

246453

EB1VA, ,

NOMESCO Finland

1.7

307.7

8816

33469

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

307.7

4663

14824

R51.80

ICD-10 Finland

Headache

2.6

307.7

9010

22830

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

14.3

307.7

9416

4710

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

29.4

307.7

387

C08CA01

ATC

amlodipine; oral

1.5

307.7

17031

75008

M01AX05

ATC

glucosamine; oral

2.1

307.7

8409

26147

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

50.3

307.7

1604

196

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

16.5

307.7

473

172

M54.8

ICD-10 Finland

Other dorsalgia

4.9

307.7

2757

3530

B01AC04

ATC

clopidogrel; oral

1.8

307.7

6805

24468

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

307.7

14619

59373

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

307.7

4579

11469

N05CF02

ATC

zolpidem; oral

1.8

307.7

8272

29304

L28

ICPC

Limited function/disability (L)

2.2

307.7

9340

27742

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.0

307.7

5232

16192

M41.9

ICD-10 Finland

Scoliosis, unspecified

13.3

307.7

663

300

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.5

307.7

3514

6262

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

18.0

307.7

2027

696

N06AX16

ATC

venlafaxine; oral

2.6

307.7

8387

21255

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.2

307.7

1350

1949

B01AB05

ATC

enoxaparin; parenteral

1.6

307.7

14256

59299

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

307.7

19838

86101

SPAT1263

SPAT

Sampling

1.6

307.7

19955

86027

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.4

307.7

1645

2936

R60.0

ICD-10 Finland

Localized oedema

1.8

307.7

5584

18905

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

307.7

28657

134587

M03BC01

ATC

orphenadrine (citrate); systemic

3.6

307.7

15344

32443

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

3804.7

307.7

7648

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

16384.0

307.7

3520

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

307.7

4461

13093

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

23.0

307.7

497

130

N06AB04

ATC

citalopram; systemic

1.8

307.7

9727

35887

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

627.1

307.7

727

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

32.5

307.7

4207

835

SPAT1153

SPAT

Removal of sutures

2.0

307.7

15830

54934

WX402

NOMESCO Finland

General anaesthesia

1.7

307.7

10834

41962

ZXA00

NOMESCO Finland

Right side

1.8

307.7

11888

44370

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.2

307.7

6947

19951

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

307.7

20269

67684

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

307.7

4225

11728

R13

ICD-10 Finland

Dysphagia

2.3

307.7

3144

8579

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

36842

180104

G83.4

ICD-10 Finland

Cauda equina syndrome

37.8

307.7

428

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

29282

142175

L86

ICPC

Back syndrome with radiating pain

10.4

307.7

6133

3928

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

307.7

8769

25448

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.5

307.7

5863

14856

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

307.7

11079

38164

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

307.7

3349

8588

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.5

307.7

3642

8945

M76.0

ICD-10 Finland

Gluteal tendinitis

5.6

307.7

1138

1225

J01FF01

ATC

clindamycin; systemic

1.7

307.7

13036

50960

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.4

307.7

6449

17525

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

50.5

307.7

1136

137

L17

ICPC

Foot/toe symptom/complaint

2.0

307.7

15980

56559

N02BF01

ATC

gabapentin; oral

7.3

307.7

9188

8799

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

13.1

307.7

4543

2245

M01AB08

ATC

etodolac; oral

2.7

307.7

3502

8160

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

307.7

12693

46689

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

48.0

307.7

14055

2356

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.4

307.7

2263

4053

M54.6

ICD-10 Finland

Pain in thoracic spine

4.2

307.7

4412

6691

M02AA10

ATC

ketoprofen; topical

2.0

307.7

7482

24412

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

307.7

3202

8852

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.9

307.7

8229

18736

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.2

307.7

28310

82858

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

22471

104817

M47.82

ICD-10 Finland

Other spondylosis, cervical region

25.4

307.7

3530

884

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

307.7

699

XX2CT

NOMESCO Finland

Other injection with CT guidance

101.8

306.0

255

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

305.8

3548

10514

M01AE51

ATC

ibuprofen, combinations; systemic

5.0

304.9

819

998

A02BA04

ATC

nizatidine; systemic

2.2

304.7

3185

9055

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.4

304.1

2445

6197

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

302.8

16516

74607

KMAK, ,

NOMESCO Finland

1.4

302.7

24379

118392

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

302.5

3943

12203

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

299.7

4893

16356

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

299.2

2206

5362

J01EA01

ATC

trimethoprim; systemic

1.5

298.5

11113

46343

M15

ICD-10 Finland

Polyarthrosis

2.5

298.1

2174

5256

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

+∞

297.9

353

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

544.1

297.7

363

M70.7

ICD-10 Finland

Other bursitis of hip

3.6

297.2

1188

2007

S06.0

ICD-10 Finland

Concussion

1.9

297.0

4850

16211

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.8

296.6

828

1046

J01DA09

ATC

[U] cefadroxil

1.5

296.2

12089

51420

R01AD12

ATC

fluticasone furoate; nasal

1.5

296.1

14636

64774

SPAT1058

SPAT

PEF monitoring instruction

2.1

295.8

3390

9994

N06AB10

ATC

escitalopram; oral

1.6

295.5

9476

38172

N06AB03

ATC

fluoxetine; oral

1.8

293.8

5312

18332

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

292.9

7984

30899

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

292.7

6113

22018

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

26.0

292.5

300

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.5

292.2

2100

5039

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.1

292.2

1475

2909

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

292.0

2225

5495

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

291.2

24268

118257

M19.8

ICD-10 Finland

Other specified arthrosis

2.7

291.0

1859

4197

R09

ICPC

Sinus symptom/complaint

2.0

290.8

3821

11853

R35

ICD-10 Finland

Polyuria

2.2

290.6

3071

8765

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

290.2

344

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

290.2

9896

40419

NA1BG, ,

SPAT

4.1

289.5

972

1439

R03AC03

ATC

terbutaline; inhalant

1.7

287.7

6121

22155

N17

ICPC

Vertigo/dizziness

1.8

285.4

5500

19339

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

283.8

10489

43597

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

283.5

336

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

283.3

11180

47139

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

283.0

2546

6787

XF402

NOMESCO Finland

ECG with work load test

1.9

283.0

4320

14112

R03BA08

ATC

ciclesonide; inhalant

1.9

282.8

3969

12598

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

282.3

2268

5743

WZC00, ,

SPAT

1.7

281.9

6791

25427

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

280.3

2602

7032

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

280.0

11809

50480

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.2

278.5

2829

7941

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

15.4

278.2

341

133

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

278.1

8429

33443

C03CA01

ATC

furosemide; systemic

1.5

278.1

12273

52950

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.4

277.1

842

1147

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

276.9

3319

9946

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

276.7

4472

14881

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

5.7

276.5

639

669

H01

ICPC

Ear pain/earache

1.8

276.0

5331

18747

NF1DA

NOMESCO Finland

X-ray of hips

3.9

275.8

992

1550

S29

ICPC

Skin symptom/complaint other

1.6

275.5

9153

37104

R06AX27

ATC

desloratadine; oral

1.5

275.4

13171

57740

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

274.9

5592

19964

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

274.1

2791

7841

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

273.5

2834

8019

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.8

273.2

1643

3588

M03BX01

ATC

baclofen; systemic

4.0

273.1

944

1430

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

272.9

3067

8965

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.4

272.7

2216

5639

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

335.2

271.6

336

TQW40, ,

SPAT

1.8

271.2

4574

15424

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.0

271.1

3282

9870

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

270.2

13363

58931

L04AX03

ATC

methotrexate; systemic

1.9

268.9

4116

13447

J45

ICD-10 Finland

Asthma

1.8

268.2

4718

16119

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

266.3

5859

21376

ZZH40

NOMESCO Finland

Substitute of bone

7.6

266.2

488

387

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

26.3

265.8

272

D06

ICPC

Abdominal pain localized other

1.9

265.3

4015

13066

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

264.1

1397

2833

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

264.0

7230

27944

C09CA06

ATC

candesartan; oral

1.5

263.0

10944

46555

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

262.8

4050

13258

K07.60

ICD-10 Finland

Snapping jaw

2.3

261.9

2371

6334

U02

ICPC

Urinary frequency/urgency

1.7

261.6

6315

23620

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.5

261.6

1905

4598

SFA00

NOMESCO Finland

Small restoration

1.7

260.2

6388

23998

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

259.0

5634

20479

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

258.8

3675

11699

P01BA02

ATC

hydroxychloroquine; oral

2.0

258.6

3413

10588

WX002

NOMESCO Finland

Sedation and analgesia

1.6

258.0

7974

31725

R03BB04

ATC

tiotropium bromide; inhalant

1.9

256.3

4184

13951

NA3CG, ,

SPAT

5.0

255.7

684

830

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

254.3

10633

45228

P06

ICPC

Sleep disturbance

1.7

254.1

5914

21892

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.3

253.7

794

1109

Z71.8

ICD-10 Finland

Other specified counselling

1.4

253.3

15575

71386

T90

ICPC

Diabetes non-insulin dependent

1.5

253.2

10433

44238

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.1

253.1

1231

2371

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

252.2

3129

9488

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.4

251.6

16152

74583

EBA00

NOMESCO Finland

Extraction of tooth

1.4

251.5

16614

77106

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

10.5

251.2

372

213

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

251.0

3846

12557

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

249.5

9865

41448

C09CA01

ATC

losartan; oral

1.5

249.1

10925

46902

M47.8

ICD-10 Finland

Other spondylosis

67.7

248.5

215

R5110, ,

SPAT

1.9

248.0

3578

11446

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

247.9

3371

10564

N05CD07

ATC

temazepam; oral

1.8

247.6

4729

16544

G43.9

ICD-10 Finland

Migraine, unspecified

2.1

247.4

2734

7931

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

246.2

8528

34794

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.8

245.7

1498

3294

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

26.7

245.4

250

A28

ICPC

Limited function/disability NOS

1.6

244.0

7027

27451

L83

ICPC

Neck syndrome

7.2

244.0

467

392

M01AB01

ATC

indometacin; systemic, rectal

2.0

243.9

2950

8858

A01AB09

ATC

miconazole; local oral

1.9

243.7

3514

11237

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

243.7

3662

11875

R74

ICPC

Upper respiratory infection acute

1.4

242.9

15191

69717

N06AX03

ATC

mianserin; oral

2.4

242.7

2045

5287

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

242.3

7662

30604

B01AF01

ATC

rivaroxaban; oral

1.7

241.8

5118

18438

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

241.6

8854

36563

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

241.5

4198

14267

XKC03

NOMESCO Finland

Water cystometry

2.9

240.8

1306

2687

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

81.3

240.2

204

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

240.2

4447

15406

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

240.1

2566

7343

XKD00

NOMESCO Finland

Uroflowmetry

1.6

239.1

6303

24076

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

238.9

5274

19221

C05AA08

ATC

fluocortolone; rectal, topical

1.7

238.7

5809

21734

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

238.2

2323

6402

H02BX01

ATC

methylprednisolone, combinations; systemic

2.3

238.1

2025

5257

SPAT1254

SPAT

Administration of medicine

1.7

237.1

5988

22620

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

26.0

236.8

243

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

236.2

5782

21663

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

235.8

5873

22103

TAC99

NOMESCO Finland

Other blockade for chronic pain

8.6

235.7

395

276

E0000UV, ,

ATC

1.4

235.6

18952

90693

C08CA13

ATC

lercanidipine; oral

1.6

232.9

5950

22535

L05

ICPC

Flank/axilla symptom/complaint

2.0

232.2

2789

8348

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

232.1

4163

14277

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

232.1

2501

7179

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

231.9

3089

9603

H02AB07

ATC

prednisone; oral

1.7

231.1

5666

21228

J46

ICD-10 Finland

Status asthmaticus

2.9

231.0

1289

2696

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.4

230.9

1889

4817

SPAT1312

SPAT

General health counselling

1.4

230.8

13399

60557

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.4

230.5

991

1760

M53.9

ICD-10 Finland

Dorsopathy, unspecified

9.3

230.1

366

236

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

228.0

12104

53788

M41.8

ICD-10 Finland

Other forms of scoliosis

14.9

227.8

283

114

N30.0

ICD-10 Finland

Acute cystitis

1.6

227.8

7265

29036

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

227.3

4814

17329

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

227.2

3097

9705

D07AD01

ATC

clobetasol; topical

1.6

226.7

7284

29158

D02

ICPC

Abdominal pain epigastric

2.0

226.3

2741

8229

NBG10

NOMESCO Finland

Acromioplastia

3.2

226.1

1064

2006

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

226.1

6620

25925

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

30.3

225.9

223

ZXD05

NOMESCO Finland

Urgent procedure

1.4

224.9

13400

60789

M89.0

ICD-10 Finland

Algoneurodystrophy

6.4

224.6

468

436

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

224.3

2194

6052

K08.80

ICD-10 Finland

Toothache NOS

1.8

224.1

4111

14189

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

223.7

7217

28910

M75.8

ICD-10 Finland

Other shoulder lesions

2.5

223.6

1710

4223

M65.3

ICD-10 Finland

Trigger finger

2.3

223.3

2089

5654

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

222.9

4509

16016

M77.4

ICD-10 Finland

Metatarsalgia

2.0

222.8

2718

8180

72519

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis et lumbosacralis NUD

+∞

221.8

263

D11

ICPC

Diarrhoea

1.7

219.7

5318

19840

WX320

NOMESCO Finland

Spinalanesthesy

1.5

219.0

10451

45451

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

219.0

2234

6269

A04

ICPC

Weakness/tiredness general

1.6

218.9

6811

27042

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.4

218.7

1819

4672

R25.2

ICD-10 Finland

Cramp and spasm

3.0

218.6

1159

2352

A98

ICPC

Health maint/preventive medicine

1.8

218.0

49742

282480

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

217.9

3145

10048

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

5.2

217.6

558

650

SPAT1202

SPAT

Intra-articular injection

2.8

216.3

1271

2737

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.2

216.3

2043

5551

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.5

215.6

1585

3839

J20

ICD-10 Finland

Acute bronchitis

1.7

214.5

4604

16620

M75.2

ICD-10 Finland

Bicipital tendinitis

2.9

214.3

1211

2551

N06AX26

ATC

vortioxetine; oral

1.9

214.2

3476

11542

Z00.0

ICD-10 Finland

General medical examination

1.5

214.0

8216

34169

SGA01

NOMESCO Finland

Emergency treatment

1.5

213.8

7512

30647

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

213.4

2804

8668

J05AB01

ATC

aciclovir; systemic

1.5

213.0

9473

40602

C07AB02

ATC

metoprolol; systemic

1.5

212.6

7885

32544

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.9

211.9

1181

2468

J01MA12

ATC

levofloxacin; systemic

1.5

211.8

7680

31543

UJD02

NOMESCO Finland

Gastroscopy

2.2

210.8

1994

5420

AN1

Coronary angiography

1.8

210.5

4133

14543

I20.09

ICD-10 Finland

Unstable angina

2.1

210.2

2214

6292

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

210.1

12174

54827

R51

ICD-10 Finland

Headache

2.0

210.1

2510

7492

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

55.6

209.9

186

G04BD08

ATC

solifenacin; oral

2.0

209.9

2558

7692

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

209.8

2482

7381

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

209.6

9389

40281

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

209.4

6228

24445

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

208.9

9990

43409

S22.3

ICD-10 Finland

Fracture of rib

1.9

208.4

3038

9734

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

208.0

2528

7593

ZXD20

NOMESCO Finland

Day surgery

1.6

207.5

5359

20313

H02.3

ICD-10 Finland

Blepharochalasis

2.0

206.6

2640

8077

R01AD01

ATC

beclometasone; nasal

1.6

205.8

6474

25738

R00.2

ICD-10 Finland

Palpitations

1.8

205.5

3424

11459

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.1

204.9

446

437

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

204.8

1943

5287

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

204.3

4845

17958

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

203.9

4957

18494

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

203.9

2975

9534

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.8

203.5

1232

2697

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

202.9

13332

61308

N06AA12

ATC

doxepin; systemic

2.2

201.5

2024

5640

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

201.5

2489

7520

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

4.8

201.1

561

708

M75.5

ICD-10 Finland

Bursitis of shoulder

2.9

201.0

1085

2225

NF1AA, ,

SPAT

2.2

200.9

2050

5750

SPAT1240

SPAT

Therapeutic discussion

1.7

200.7

4372

15833

RF210, ,

NOMESCO Finland

2.8

200.6

1177

2532

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.2

200.4

511

592

N03AF01

ATC

carbamazepine; oral, rectal

2.2

199.9

2053

5773

S80.0

ICD-10 Finland

Contusion of knee

1.8

199.5

3308

11051

M53.8

ICD-10 Finland

Other specified dorsopathies

7.6

199.4

365

289

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.1

198.8

987

1924

1220

FHL

Arthroscopy

2.4

198.8

1619

4116

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

198.8

1871

5073

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

198.3

4713

17472

P03

ICPC

Feeling depressed

1.7

198.3

4343

15750

OAB93, ,

SPAT

1.9

198.1

3169

10465

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

197.6

10028

44004

R06.5

ICD-10 Finland

Mouth breathing

1.8

197.4

3866

13582

J01FA15

ATC

telithromycin; oral

1.7

197.4

4113

14709

A29

ICPC

General symptom/complaint other

1.6

196.7

5600

21728

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

196.6

2788

8845

NG1DA

NOMESCO Finland

X-ray of knees

3.5

196.6

808

1391

L04

ICPC

Chest symptom/complaint

1.9

196.5

2729

8595

C10AA04

ATC

fluvastatin; oral

1.8

196.3

3233

10776

R15

ICD-10 Finland

Faecal incontinence

2.8

196.1

1159

2503

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

196.1

4719

17548

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

196.0

4722

17565

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.2

195.9

1985

5551

E66.8

ICD-10 Finland

Other obesity

2.0

194.7

2493

7629

L18

ICPC

Muscle pain

2.2

194.3

1837

4990

L90

ICPC

Osteoarthrosis of knee

1.9

194.0

2746

8705

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

193.8

4274

15523

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

8.1

193.0

337

250

L88

ICPC

Rheumatoid/seropositive arthritis

2.3

192.7

1672

4375

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.3

192.2

1646

4281

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.4

192.1

826

1467

N39.3

ICD-10 Finland

Stress incontinence

1.9

192.0

2911

9443

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

191.5

5787

22765

M48

ICD-10 Finland

Other spondylopathies

25.2

191.4

198

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

191.4

9409

41008

N07BA03

ATC

varenicline; oral

2.1

191.2

2229

6587

Z3231

NOMESCO Finland

Registered nurse

1.4

189.0

11360

51332

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

20.2

188.9

209

M50

ICD-10 Finland

Cervical disc disorders

6.3

188.9

402

384

R75

ICPC

Sinusitis acute/chronic

2.1

188.8

2095

6074

K59.0

ICD-10 Finland

Constipation

2.0

188.8

2299

6906

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

188.5

4400

16221

U07

ICPC

Urine symptom/complaint other

1.8

188.5

3505

12121

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

188.5

1684

4463

R11

ICD-10 Finland

Nausea and vomiting

1.8

188.4

3569

12411

G04CA01

ATC

alfuzosin; oral

1.6

188.3

4898

18572

OAB42, ,

SPAT

1.6

188.0

5597

21933

R51.81

ICD-10 Finland

Facial pain NOS

2.9

187.7

1052

2205

N05BA12

ATC

alprazolam; oral

1.7

187.6

3993

14355

L09

ICPC

Arm symptom/complaint

2.1

187.4

2103

6123

H57.1

ICD-10 Finland

Ocular pain

2.3

187.4

1731

4655

K80

ICPC

Cardiac arrhythmia NOS

1.8

187.2

3515

12190

-1, ,

NOMESCO Finland

1.4

185.5

14349

67566

S21

ICPC

Skin texture symptom/complaint

1.5

185.5

6438

26120

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

185.0

5230

20237

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.3

184.9

833

1526

L20

ICPC

Joint symptom/complaint NOS

2.3

184.5

1694

4543

M15.8

ICD-10 Finland

Other polyarthrosis

3.1

183.7

887

1699

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.2

183.7

1769

4841

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

183.1

10254

45719

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

182.9

3002

9988

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

182.4

3568

12519

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

182.0

1045

2220

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

1269.7

181.6

218

M77.0

ICD-10 Finland

Medial epicondylitis

2.6

180.9

1188

2716

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.3

180.9

828

1533

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

180.8

6917

28644

S83.2

ICD-10 Finland

Tear of meniscus, current

1.8

180.7

3000

10016

TAB00

NOMESCO Finland

Lumbar puncture

2.2

180.1

1821

5085

A03

ICPC

Fever

1.5

179.9

7506

31639

L11

ICPC

Wrist symptom/complaint

1.7

179.8

3852

13867

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

12.1

179.3

245

121

P76

ICPC

Depressive disorder

1.8

178.8

2904

9627

C10AA03

ATC

pravastatin; oral

1.9

178.2

2714

8812

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

178.1

1381

3430

A07AA02

ATC

nystatin; oral

2.0

178.0

2273

6944

R21

ICPC

Throat symptom/complaint

1.4

177.6

9116

39981

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.5

177.4

1254

2977

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.2

177.3

379

364

G50.1

ICD-10 Finland

Atypical facial pain

3.3

177.1

794

1450

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

220.5

176.4

222

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

176.1

2640

8526

WZA00

NOMESCO Finland

Concise certificate

1.9

176.1

2763

9058

M41.5

ICD-10 Finland

Other secondary scoliosis

52.1

175.6

157

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

175.3

4570

17321

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

175.1

2291

7060

R52.0

ICD-10 Finland

Acute pain

2.4

174.4

1416

3593

R06AX22

ATC

ebastine; oral

1.5

174.2

7353

31046

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.4

174.1

1394

3514

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

4.4

173.9

532

729

A10BA02

ATC

metformin; oral

1.4

173.8

11821

54409

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

173.5

1086

2420

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

173.2

5542

22055

N06AB06

ATC

sertraline; oral

1.6

172.7

4749

18235

R12

ICD-10 Finland

Heartburn

1.7

172.5

3574

12740

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

172.0

2311

7188

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

171.4

3097

10609

M09AX01

ATC

hyaluronic acid; parenteral

2.2

170.8

1708

4747

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.9

170.4

919

1883

-, ,

ICD-10 Finland

2.8

170.0

974

2067

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

169.4

3243

11300

M48.8

ICD-10 Finland

Other specified spondylopathies

27.6

169.4

171

G56.4

ICD-10 Finland

Causalgia

9.1

169.3

273

180

L60.0

ICD-10 Finland

Ingrowing nail

2.0

168.4

2003

5960

XQ800

NOMESCO Finland

Prick test

1.8

168.2

2956

10039

R29

ICPC

Respiratory symptom/complaint other

1.8

167.9

2873

9677

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

167.9

5670

22828

SDA03

NOMESCO Finland

Periodontal treatment

1.3

167.6

18607

92086

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

8.6

167.5

280

195

ZXA10

NOMESCO Finland

Bilateral

1.5

167.3

7200

30493

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

3.7

167.0

624

1003

H03AA01

ATC

levothyroxine sodium; systemic

1.4

166.4

9494

42371

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

166.2

13514

63900

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

166.2

1117

2584

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.6

166.1

1148

2694

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

166.1

4717

18245

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

165.8

3984

14777

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

165.6

3153

10967

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

165.4

3347

11847

ACC53

NOMESCO Finland

Release of ulnar nerve

3.6

165.0

648

1080

R55

ICD-10 Finland

Syncope and collapse

1.6

164.4

4435

16937

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

164.2

1060

2401

N06AX12

ATC

bupropion; oral

1.8

163.1

3143

10968

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

162.7

2313

7333

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.9

162.4

901

1877

M22.4

ICD-10 Finland

Chondromalacia patellae

2.4

162.3

1301

3281

R4120

NOMESCO Finland

Occupational therapy

1.8

160.6

2635

8757

L04AA13

ATC

[U] leflunomide

2.8

160.5

971

2124

W19

ICD-10 Finland

Unspecified fall

1.6

160.0

4031

15128

J01CA08

ATC

pivmecillinam; oral

1.3

160.0

16767

82168

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.3

159.8

701

1262

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

159.7

2191

6861

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

159.4

1515

4121

SPAT1325

SPAT

Vaccination

1.3

159.1

13201

62531

A99

ICPC

Disease/condition unspecnature/site

1.6

159.0

4303

16439

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

159.0

31947

170514

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

158.7

2385

7703

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

158.5

5131

20446

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.3

158.3

1347

3491

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

17.4

157.0

183

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.0

156.7

831

1686

K85

ICPC

Elevated blood pressure

1.5

156.6

6623

27919

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

156.2

1747

5075

A10BK03

ATC

empagliflozin; oral

1.6

156.1

4098

15537

M02AA15

ATC

diclofenac; topical

1.8

155.9

2784

9495

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.4

155.4

1212

3017

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.3

155.0

1383

3660

A02BX02

ATC

sucralfate; oral

2.2

154.9

1475

4015

RF420, ,

NOMESCO Finland

3.8

154.8

566

895

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

154.5

2526

8382

J02AC02

ATC

itraconazole; systemic

1.4

154.5

7224

31046

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

154.3

1105

2639

D19

ICPC

Teeth/gum symptom/complaint

1.3

154.2

13675

65358

C10AC01

ATC

colestyramine; oral

2.5

153.7

1153

2817

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.6

153.7

1054

2463

S01

ICPC

Pain/tenderness of skin

2.0

153.3

1933

5873

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

153.0

8346

36887

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

2.8

152.5

917

1999

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

152.3

1896

5734

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

152.0

3606

13318

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

151.9

4041

15367

A46

ICD-10 Finland

Erysipelas

1.5

151.8

5950

24689

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

151.8

180

W78

ICPC

Pregnancy

0.6

151.4

2278

23508

205

Kela drug reimbursment

Chronic hypertension

1.4

151.4

10123

46301

M01AB16

ATC

aceclofenac; oral

2.4

151.3

1239

3155

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.6

151.3

4071

15523

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

150.7

11700

54781

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

150.6

3659

13597

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

150.5

2024

6293

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

150.1

3560

13146

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.8

149.8

2397

7898

M46.4

ICD-10 Finland

Discitis, unspecified

277.3

149.4

186

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

149.4

2859

9950

J01DA06

ATC

[U] cefuroxime

1.5

149.1

5779

23916

N81.6

ICD-10 Finland

Rectocele

1.8

147.9

2361

7773

U05

ICPC

Urination problems other

1.9

147.8

2029

6352

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

147.6

1395

3784

7244A

ICD-9 Finland

Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified

+∞

147.6

175

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

147.1

1280

3350

J01MA14

ATC

moxifloxacin; systemic

1.7

147.0

3520

13027

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.4

146.9

1125

2776

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

146.9

1834

5552

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

146.7

3814

14415

WW200, ,

SPAT

1.3

146.1

12587

59810

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

145.6

2271

7421

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

11.1

145.5

208

112

F29

ICPC

Eye symptom/complaint other

1.6

145.4

4383

17163

M41.2

ICD-10 Finland

Other idiopathic scoliosis

28.1

145.3

146

S70.0

ICD-10 Finland

Contusion of hip

2.1

145.0

1524

4319

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

14.9

144.2

179

D07AC13

ATC

mometasone; topical

1.3

144.2

12226

57937

RF120, ,

NOMESCO Finland

4.1

143.8

483

715

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

143.8

2319

7658

71700, ,

ICD-8 Finland

+∞

143.3

170

M01AC02

ATC

tenoxicam; systemic, rectal

2.0

142.9

1732

5185

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

214.3

142.9

180

R03AC13

ATC

formoterol; inhalant

2.0

142.8

1923

5979

9183

FHL

Posterolateral spondylodesis

45.7

142.6

130

R50.9

ICD-10 Finland

Fever, unspecified

1.5

142.5

6188

26181

R01AD11

ATC

triamcinolone; nasal

1.6

141.9

3433

12735

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

141.6

168

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.2

141.5

664

1249

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

3.0

141.2

751

1526

N06AX05

ATC

trazodone; oral

2.5

141.2

1017

2436

S15

ICPC

Foreign body in skin

1.8

141.1

2622

9042

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

141.0

4115

15988

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

140.4

1998

6332

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

140.3

1126

2840

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

140.2

1323

3586

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

140.1

832

1801

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

139.9

3967

15307

R06AE09

ATC

levocetirizine; oral

1.5

139.7

5834

24487

WZC30, ,

SPAT

1.6

139.6

3409

12676

SPAT1211

SPAT

Application of soft bandage

1.7

139.5

3207

11738

G50.0

ICD-10 Finland

Trigeminal neuralgia

3.0

139.2

730

1471

ZXD35

NOMESCO Finland

Usual procedure

2.2

138.2

1343

3686

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

138.1

3229

11871

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

138.1

5218

21460

SPAT1283

SPAT

Restricted health certificate

1.4

137.9

7055

30766

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

27.0

137.9

140

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.1

137.7

1498

4303

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

137.7

4503

17952

N03AX11

ATC

topiramate; oral

2.5

137.3

992

2379

H13

ICPC

Plugged feeling ear

1.4

137.0

7775

34525

M75

ICD-10 Finland

Shoulder lesions

2.0

136.9

1823

5646

K04.08

ICD-10 Finland

Other specified pulpit

1.6

136.7

3365

12535

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

18.0

136.6

157

J45.8

ICD-10 Finland

Mixed asthma

2.3

135.9

1174

3062

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

135.8

2851

10178

SPAT1262

SPAT

Handing over of treatment supplies

1.4

135.3

6746

29270

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

135.3

1098

2784

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

135.3

1798

5564

K05.30

ICD-10 Finland

Periodontitis complex

1.4

135.2

6194

26456

H02

ICPC

Hearing complaint

1.5

135.0

5667

23800

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

135.0

6879

29967

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

134.8

1472

4235

WZC30

NOMESCO Finland

Teaching

1.4

134.5

6584

28471

OAA65, ,

SPAT

1.4

134.3

8379

37794

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

134.2

8971

40919

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.7

134.2

827

1827

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

15.2

134.1

165

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

134.1

159

M19.2

ICD-10 Finland

Other secondary arthrosis

3.4

133.8

580

1036

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

983.9

133.6

161

N41.1

ICD-10 Finland

Chronic prostatitis

2.5

133.6

978

2361

C08DA01

ATC

verapamil; systemic

2.1

133.5

1543

4537

UJH02

NOMESCO Finland

Anoscopy

2.0

132.9

1598

4769

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

132.7

1852

5829

A08

ICPC

Swelling

1.8

132.7

2164

7169

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

132.6

1534

4512

S22

ICPC

Nail symptom/complaint

1.7

132.6

2687

9498

M50.2

ICD-10 Finland

Other cervical disc displacement

47.8

132.5

120

H29

ICPC

Ear symptom/complaint other

1.5

132.4

4845

19782

D82

ICPC

Teeth/gum disease

1.3

132.3

16492

82164

N07CA01

ATC

betahistine; oral

1.7

132.2

2668

9420

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

2.8

132.1

763

1626

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

3.7

132.1

503

820

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

132.1

1463

4232

SPAT1106

SPAT

Acupuncture

5.3

132.0

326

366

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

131.9

1698

5195

C01CA24

ATC

epinephrine; parenteral

1.8

131.6

2454

8468

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

131.4

4423

17735

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

131.2

6482

28064

SPAT1255

SPAT

Intravenous administration of medicine

1.7

130.5

2568

9001

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

7.6

130.0

236

185

EC1VA, ,

NOMESCO Finland

1.9

130.0

1960

6330

ZXC95

NOMESCO Finland

Use of surgical navigator

3.6

130.0

516

867

L01BA01

ATC

methotrexate; systemic

2.2

129.9

1303

3623

U01

ICPC

Dysuria/painful urination

1.7

129.8

2984

10914

Z30.2

ICD-10 Finland

Sterilization

1.6

129.8

4073

16076

M23.8

ICD-10 Finland

Other internal derangements of knee

2.0

129.5

1512

4462

H92.0

ICD-10 Finland

Otalgia

1.7

129.5

2590

9120

JAH01

NOMESCO Finland

Laparoscopy

1.9

129.4

1834

5801

R10.0

ICD-10 Finland

Acute abdomen

2.1

129.3

1333

3747

M67.4

ICD-10 Finland

Ganglion

1.7

129.2

2798

10072

SPAT1059

SPAT

Spirometry at the office

1.9

129.2

1857

5903

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

128.9

3009

11050

J05AB11

ATC

valaciclovir; oral

1.4

128.9

5891

25133

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

128.9

990

2446

R07.0

ICD-10 Finland

Pain in throat

1.7

128.8

2971

10877

TAC00

NOMESCO Finland

Peripheral nerve block

7.9

128.7

227

171

SPAT1285

SPAT

Provision of consultation response

1.9

128.5

1976

6422

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

128.3

2364

8128

F34.1

ICD-10 Finland

Dysthymia

2.1

128.1

1463

4282

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

127.7

10450

49117

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

3.1

127.6

631

1227

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

127.0

5051

20969

L92

ICPC

Shoulder syndrome

2.5

126.8

923

2222

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

126.7

2700

9674

NA2AD

NOMESCO Finland

Thoracic spine CT examination

5.8

126.5

288

297

N07BC02

ATC

methadone; systemic

8.4

126.4

214

152

A01AB04

ATC

amphotericin B; local oral

2.0

126.3

1650

5074

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

126.0

10859

51404

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

126.0

4660

19058

N62

ICD-10 Finland

Hypertrophy of breast

2.0

125.8

1616

4939

P20

ICPC

Memory disturbance

1.5

125.7

4939

20450

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.0

125.6

1532

4595

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

125.6

1145

3058

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

125.4

715

1513

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

125.3

1200

3272

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

124.8

781

1740

SPAT1104

SPAT

Monitoring of emergency patient

1.7

124.7

2409

8396

M25.2

ICD-10 Finland

Flail joint

3.5

124.6

518

899

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.0

124.5

1500

4479

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

124.3

1675

5206

SPAT1210

SPAT

Application of cast or individual aid

2.0

124.0

1538

4641

K04.0

ICD-10 Finland

Pulpitis

1.6

123.8

3846

15139

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.8

123.7

723

1551

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

3.3

123.6

554

1012

SPAT1197

SPAT

Extensive health check-up of expecting family

0.6

123.5

1897

19529

XF404

NOMESCO Finland

Ambulatory ECG

1.6

123.4

3151

11836

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

123.4

2315

7999

V252A

ICD-9 Finland

Contraceptive management, Sterilisation

1.7

123.4

2613

9346

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

122.4

1336

3842

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.5

122.4

4362

17695

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

122.0

1298

3695

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

121.8

1049

2732

R33

ICD-10 Finland

Retention of urine

1.6

121.7

2946

10916

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.9

121.7

1813

5831

L99

ICPC

Musculoskeletal disease other

2.5

121.1

903

2199

NBL05

NOMESCO Finland

Arthroscopic suture or reinsertation of rotator cuff of shoulder

2.9

120.9

673

1405

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

120.7

2746

10012

71312

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis

+∞

120.6

143

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

119.8

1265

3590

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

35.8

119.7

114

7233A

ICD-9 Finland

Other disorders of cervical region, Cervicobrachial syndrome (diffuse)

+∞

119.7

142

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.7

119.5

2292

7969

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

119.4

2216

7631

M51.4

ICD-10 Finland

Schmorl nodes

132.3

119.4

155

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

119.1

3566

13914

M47

ICD-10 Finland

Spondylosis

5.1

119.1

307

360

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

118.7

812

1895

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

1.4

118.5

8012

36525

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

863.8

118.5

143

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

37.2

118.5

112

R1100, ,

SPAT

3.1

118.3

588

1147

L89

ICPC

Osteoarthrosis of hip

2.1

118.2

1338

3902

N06AX22

ATC

agomelatine; oral

2.4

118.0

967

2462

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.1

117.9

1218

3427

H93.1

ICD-10 Finland

Tinnitus

1.7

117.7

2765

10165

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.2

117.6

1142

3132

A10BJ06

ATC

semaglutide; parenteral

1.8

117.6

2086

7088

SPAT1043

SPAT

Audiometry

1.6

117.5

3485

13566

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

117.4

2585

9340

M10.9

ICD-10 Finland

Gout, unspecified

1.7

117.4

2569

9267

R04

ICPC

Breathing problem other

2.0

117.4

1558

4816

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.5

117.4

836

1991

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.6

117.2

459

764

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

116.9

1638

5159

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

116.9

2598

9412

F01

ICPC

Eye pain

2.2

116.7

1186

3314

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

116.5

9677

45493

J01MA06

ATC

norfloxacin; oral

1.5

116.2

4856

20335

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

116.0

3175

12126

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

116.0

1030

2719

S04

ICPC

Lump/swelling localized

1.5

115.3

4420

18192

A02BA03

ATC

famotidine; systemic

2.1

115.1

1320

3868

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.4

115.1

884

2184

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

284.1

115.0

143

SPAT1360

SPAT

Extensive global examination

1.7

114.7

2577

9362

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

114.6

8159

37475

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.0

114.4

587

1168

N06AB05

ATC

paroxetine; oral

1.7

113.7

2316

8190

G44.0

ICD-10 Finland

Cluster headache syndrome

3.4

113.5

483

852

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

113.5

1441

4385

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

111.3

113.3

149

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.1

113.2

568

1115

J01

ICD-10 Finland

Acute sinusitis

1.7

113.1

2241

7864

A06AC51

ATC

ispaghula, combinations; oral

1.8

112.6

1780

5834

WVA20, ,

SPAT

2.0

112.5

1428

4345

G04BD07

ATC

tolterodine; oral

1.9

112.3

1628

5187

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

112.2

10741

51464

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.3

112.1

974

2547

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

24.1

111.8

117

R07.2

ICD-10 Finland

Precordial pain

2.5

111.6

807

1936

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.9

111.5

392

602

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

111.5

2320

8253

7213A

ICD-9 Finland

Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy

+∞

111.3

132

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.5

111.3

838

2051

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

111.2

10942

52615

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

20.2

110.5

122

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.5

110.5

4012

16322

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

4.3

110.3

341

472

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

110.3

2101

7289

P01

ICPC

Feeling anxious/nervous/tense

1.4

110.0

4976

21145

C09DA01

ATC

losartan and diuretics; oral

1.5

110.0

3990

16228

UDC00

NOMESCO Finland

Ear microscopy

1.6

109.7

2791

10466

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.1

109.5

1260

3697

R06AX13

ATC

loratadine; oral

1.4

109.1

5951

26154

N03A

ATC

ANTIEPILEPTICS

16.0

108.8

131

C03AA03

ATC

hydrochlorothiazide; oral

1.6

108.1

3128

12098

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

3.5

107.8

442

760

R49.01

ICD-10 Finland

Functional dysphonia

2.1

107.8

1115

3138

R06.2

ICD-10 Finland

Wheezing

1.8

107.5

1697

5558

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.5

107.5

3497

13891

M40.1

ICD-10 Finland

Other secondary kyphosis

56.7

107.5

B02AA02

ATC

tranexamic acid; systemic

1.4

107.5

5835

25618

A10BH01

ATC

sitagliptin; oral

1.5

107.4

3485

13834

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

107.4

2154

20742

G03DC02

ATC

norethisterone; oral

1.5

107.1

3583

14319

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

107.1

3565

14232

ZA1.0

ICD-10 Finland

Shoulder region

2.3

107.1

921

2397

S20.2

ICD-10 Finland

Contusion of thorax

1.7

106.7

2070

7217

SAA04

NOMESCO Finland

Special examination of mouth

1.8

106.6

1892

6427

G43.3

ICD-10 Finland

Complicated migraine

2.7

106.5

688

1559

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

106.0

3503

13960

K03.80

ICD-10 Finland

Irradiated enamel

1.7

106.0

2207

7850

OAA81, ,

SPAT

1.9

105.9

1613

5223

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

105.6

1689

5555

K03.00

ICD-10 Finland

Approximal wear

1.6

105.4

3147

12259

7210A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis without myelopathy

+∞

105.4

125

M20.2

ICD-10 Finland

Hallux rigidus

2.1

105.3

1118

3179

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

104.9

1325

4023

D01BA02

ATC

terbinafine; oral

1.3

104.8

10489

50483

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

104.7

1540

4929

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

104.7

5021

21556

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

2.9

104.6

571

1179

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

104.5

6442

28879

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3036481) Cortisol [Moles/volume] in Serum or Plasma

6366

22588

1.77

323.31

2.3

2.4

363.83

388.10

nmol/l

16.41

5849

21101

(3045414) Leukocytes [Presence] in Urine

6184

21777

1.78

321.93

2.1

2.0

0.02

0.03

estimate

0.27

1117

4645

(3024731) MCV [Entitic mean volume] in Red Blood Cells

50761

286719

2.34

320.93

29.0

21.3

91.25

90.83

84.48

50479

283606

(3035941) MCH [Entitic mass]

50759

286706

2.33

320.83

29.0

21.3

30.40

30.27

55.52

50477

283595

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

50760

286727

2.33

320.43

29.7

21.8

40.75

41.13

1.79

50466

283464

(3010813) Leukocytes [#/volume] in Blood

50767

286788

2.34

320.29

29.2

21.4

6.84

6.70

e9/l

29.66

50082

279525

(3026361) Erythrocytes [#/volume] in Blood

50760

286750

2.33

319.71

29.1

21.3

4.49

4.52

e12/l

23.05

50088

279474

(3000963) Hemoglobin [Mass/volume] in Blood

50767

286812

2.33

319.54

29.3

21.5

135.73

135.92

g/l

2.13

50486

283756

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4659

15031

1.93

318.42

1.3

51.40

50.19

au/ml

0.12

235

1027

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3137

8713

2.22

317.92

1.3

1.2

0.88

0.84

u/ml

0.07

327

525

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

45747

248999

1.70

307.65

17.2

13.9

82.13

83.00

ml/min/173m2

16.66

43013

227798

(3023103) Potassium [Moles/volume] in Serum or Plasma

49357

261421

2.85

307.65

22.1

16.5

3.98

3.96

mmol/l

54.58

48825

255234

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

14514

61164

1.57

307.65

2.5

2.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

15666

64863

1.62

307.65

2.5

2.3

2.71

2.81

mg/l

7.05

13802

55822

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

27616

117929

1.83

307.65

3.0

2.7

—

estimate

—

(3008898) HLA-B27 [Presence]

3246

6902

2.92

307.65

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

18394

81861

1.52

307.65

4.1

4.3

7.33

8.83

mg/mmol

4.28

11588

51446

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5466

17955

1.91

307.65

2.5

2.2

5.95

8.39

ug/l

14.45

4830

15706

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

7518

26995

1.77

307.65

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

14294

53259

1.82

307.65

1.8

1.7

1.01

1.30

mg/l

23.26

11094

41241

(3029937) Albumin [Presence] in Urine by Test strip

16863

71555

1.59

307.65

4.8

3.6

0.00

estimate

0.66

4908

25565

(3003396) Base excess in Arterial blood by calculation

7713

27510

1.79

307.65

7.3

8.2

1.13

0.80

mmol/l

10.48

6290

22691

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

48770

257773

2.62

307.65

19.4

13.9

22.07

25.07

mg/l

73.97

42120

208101

(3012516) Albumin [Mass/volume] in Urine

18219

80082

1.54

307.65

3.5

3.6

41.72

50.72

mg/l

5.99

11749

51237

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8001

28669

1.78

307.65

1.9

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

20642

76996

1.98

307.65

3.0

2.6

65.96

70.51

u/l

0.20

19305

71385

(3019060) Gas panel - Arterial blood

4451

13205

2.10

307.65

4.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17192

68075

1.75

307.65

3.2

3.1

1044.42

1516.84

ng/l

40.55

14728

58117

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

10409

39384

1.72

307.65

2.0

1.8

—

(3022096) Basophils/Leukocytes in Blood

25939

120053

1.56

307.65

6.9

6.4

0.69

0.68

4.93

24504

112722

(3019198) Lymphocytes [#/volume] in Blood

29647

132160

1.77

307.65

6.6

6.2

1.96

1.90

e9/l

4.81

26731

115737

(3006315) Basophils [#/volume] in Blood

29201

129218

1.77

307.65

6.6

6.2

0.04

e9/l

7.75

25795

110588

(3019069) Monocytes/Leukocytes in Blood

26050

120246

1.57

307.65

6.9

6.4

8.76

8.81

1.79

24651

113133

(3009261) Glucose [Presence] in Urine by Test strip

30261

136339

1.75

307.65

4.5

3.5

0.21

0.30

estimate

0.16

5001

27053

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

49897

275678

2.37

307.65

14.0

10.9

27.11

26.64

u/l

5.51

48988

267842

(3019150) Specific gravity of Urine by Refractometry

15614

56328

1.92

307.65

4.7

3.5

1.11

1.13

kg/l

0.05

10597

36587

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

22540

90422

1.85

307.65

4.2

3.3

50.30

69.18

ng/l

1.58

15308

59552

(3018010) Neutrophils/Leukocytes in Blood

26100

121335

1.56

307.65

6.7

6.2

56.75

57.56

24.21

25074

116167

(3027801) Oxygen [Partial pressure] in Arterial blood

7785

27627

1.80

307.65

7.3

8.3

12.31

12.64

kpa

5.94

7468

26552

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5033

16346

1.92

307.65

2.5

2.4

18.96

20.65

au/ml

0.76

480

2037

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

25208

109402

1.71

307.65

2.3

2.0

97.31

96.03

pmol/l

3.76

13682

59109

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4791

13850

2.17

307.65

7.0

24.63

24.41

mmol/l

3.72

4575

13229

(3002030) Lymphocytes/Leukocytes in Blood

26482

123830

1.55

307.65

6.8

6.3

28.39

27.66

22.45

25292

117714

(3032080) INR in Blood by Coagulation assay

26798

111952

1.86

307.65

13.3

14.2

1.20

1.26

inr

35.63

22393

93182

(3037467) Urinalysis macro (dipstick) panel - Urine

36834

174169

1.86

307.65

5.3

4.1

2.70

4.39

0.38

242

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

28871

122269

1.90

307.65

7.3

7.1

1.21

mmol/l

0.62

25526

104944

(3013826) Glucose [Moles/volume] in Serum or Plasma

33154

146758

1.93

307.65

5.5

4.9

6.63

6.73

mmol/l

13.26

31715

137909

(3013512) EKG study

18423

82027

1.52

307.65

3.8

3.4

0.78

0.73

0.35

179

(3009508) Creatinine [Moles/volume] in Urine

19504

87058

1.53

307.65

3.5

7.72

7.77

mmol/l

0.91

16820

74183

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

45177

244492

1.69

307.65

4.7

4.0

1.37

1.27

mmol/l

116.60

42427

227455

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

41207

185258

2.47

307.65

5.3

3.8

11.22

11.64

mm/h

7.59

39329

173139

(3035350) Ketones [Presence] in Urine by Test strip

30089

135300

1.75

307.65

4.5

3.5

3.08

3.99

estimate

0.44

5273

28576

(3013650) Neutrophils [#/volume] in Blood by Automated count

31718

145315

1.75

307.65

8.9

9.8

4.14

e9/l

0.01

28125

125144

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

35606

183368

1.48

307.65

3.8

3.1

49.24

46.41

u/l

6.59

33839

173480

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12989

38875

2.31

307.65

1.4

1.3

7.38

12.35

u/ml

14.84

5072

15442

(3042936) Bacteria identified in Isolate by Culture

9055

34911

1.66

307.65

2.2

2.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

26115

111093

1.79

307.65

5.0

5.1

36.22

35.70

g/l

41.36

24608

104140

(3044889) 12 lead EKG panel

36356

176914

1.72

307.65

4.5

3.7

2491.99

1937.88

0.10

101

287

(3020564) Creatinine [Moles/volume] in Serum or Plasma

50319

277115

2.66

307.65

24.4

18.0

76.88

77.32

umol/l

2.49

49984

273682

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

46195

242447

2.06

307.65

7.1

5.8

39.43

38.90

mmol/mol

30.14

43920

227780

(3021601) Nitrite [Presence] in Urine by Test strip

29692

133733

1.74

307.65

4.4

3.4

0.00

estimate

0.43

5162

28045

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

41257

194166

2.21

307.65

8.7

7.9

76.38

79.11

u/l

27.13

39716

184204

(3019977) pH of Arterial blood

7787

27696

1.79

307.65

7.4

8.3

7.42

0.58

4645

14573

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19687

87894

1.53

307.65

3.5

3.3

32.09

33.91

u/l

1.73

18693

83091

(3031040) Bacteria [#/volume] in Urine by Automated count

35394

164837

1.84

307.65

5.6

4.1

1483.29

1619.81

e6/l

0.13

448

2429

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

40381

200125

1.85

307.65

4.9

4.2

14.73

14.67

pmol/l

4.96

37862

184704

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14054

58230

1.60

307.65

1.3

1.55

1.76

u/ml

1.08

3782

16227

(3007461) Platelets [#/volume] in Blood

50758

286586

2.34

307.65

29.2

21.4

253.55

251.88

e9/l

6.97

50202

280283

(3013115) Eosinophils [#/volume] in Blood

29974

133285

1.78

307.65

6.7

6.4

0.20

0.19

e9/l

4.10

26862

115762

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

47154

257203

1.85

307.65

5.5

4.7

1.43

1.46

mmol/l

34.29

44656

241077

(3019550) Sodium [Moles/volume] in Serum or Plasma

49277

260790

2.82

307.65

22.0

16.4

139.69

139.68

mmol/l

0.22

48789

255094

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

26212

108469

1.87

307.65

6.7

6.5

1.21

mmol/l

0.53

24439

100424

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

45943

239215

2.09

307.65

6.2

5.0

1.81

1.90

mu/l

36.02

43440

222432

(3026008) Bacteria identified in Urine by Culture

17113

71840

1.62

307.65

3.6

2.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

25083

114618

1.58

307.65

2.6

2.4

77.45

76.44

nmol/l

6.44

23031

104672

(3018095) Leukocytes [#/volume] in Urine

20119

93516

1.45

307.65

4.4

3.7

69.33

104.95

e6/l

11.10

14959

63594

(3011397) Hemoglobin [Presence] in Urine by Test strip

14797

58529

1.70

307.65

4.5

3.4

0.33

0.26

0.25

636

(3015377) Calcium [Moles/volume] in Serum or Plasma

19154

85090

1.53

307.65

3.0

3.7

2.35

mmol/l

0.50

17426

77687

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6679

22853

1.85

307.65

7.9

9.2

123.01

121.18

g/l

9.43

6484

22336

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

5628

17597

2.01

307.65

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7522

25709

1.87

307.65

7.7

6.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

48018

261911

1.99

307.65

6.4

5.3

2.71

2.75

mmol/l

22.32

45579

245717

(3006504) Eosinophils/Leukocytes in Blood

25943

120003

1.57

307.65

6.8

6.3

2.88

2.82

4.31

24536

112821

(3023368) Bacteria identified in Blood by Culture

15902

67822

1.57

307.65

4.4

4.2

—

(3018418) pH of Serum or Plasma

17646

72268

1.68

307.65

4.1

4.3

7.40

0.16

12851

50723

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

47421

258621

1.89

307.65

5.6

4.7

4.63

4.67

mmol/l

13.19

45136

243603

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

46778

246417

2.13

307.65

5.7

4.7

5.96

5.89

mmol/l

29.74

44043

228127

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

22916

101618

1.61

307.65

4.4

3.4

0.67

0.42

estimate

0.43

4268

23070

(40758558) Short blood count panel - Blood

17085

75305

1.52

307.65

6.0

6.5

—

(3037522) Nuclear Ab [Titer] in Serum

9844

33653

1.91

307.65

1.4

1.3

487.48

536.55

titre

1.70

1997

6990

(3019309) Folate [Moles/volume] in Red Blood Cells

10026

39219

1.65

307.65

1.8

1.7

1156.43

1142.47

nmol/l

0.80

7953

29742

(3001122) Ferritin [Mass/volume] in Serum or Plasma

26299

126581

1.47

307.65

3.4

3.1

117.79

122.43

ug/l

2.17

24793

118971

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

20079

71537

2.08

307.65

2.4

2.1

187.13

223.42

u/l

4.97

19138

67591

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13845

42634

2.27

307.65

1.4

1.3

28.57

38.44

iu/ml

4.39

4274

13049

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

30215

131458

1.86

307.65

6.2

6.6

10.62

11.78

umol/l

49.89

28928

125122

(42870588) Differential panel, method unspecified - Blood

19500

85214

1.58

307.65

6.5

6.3

6.48

5.29

—

(3002582) Erythrocytes [#/volume] in Urine

18110

80190

1.53

307.65

3.7

3.2

62.66

93.91

e6/l

1.69

14394

59578

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

7788

27640

1.80

307.65

7.3

8.3

5.10

5.07

kpa

1.17

7473

26570

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12113

46023

1.74

307.65

4.4

3.5

320.77

584.82

ng/l

7.99

9097

35054

(3001604) Monocytes [#/volume] in Blood

29116

128906

1.77

307.65

6.5

6.2

0.58

e9/l

0.97

25747

110336

(3026493) Urate [Moles/volume] in Serum or Plasma

16168

65317

1.68

307.65

2.7

2.6

336.59

343.46

umol/l

14.12

14358

58436

(40768797) Stomach Pathology biopsy report

8989

32274

1.79

307.65

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

20349

88043

1.61

307.65

3.8

3.2

1.58

1.75

e6/l

—

(3016502) Oxygen saturation in Arterial blood

7038

24375

1.83

307.65

7.5

8.7

95.90

95.55

4.52

6747

23542

(3015736) pH of Urine

24696

107436

1.69

307.65

4.0

3.1

6.24

6.19

9.25

14098

60237

(3021960) Folate [Moles/volume] in Serum or Plasma

16454

68148

1.64

307.65

1.8

1.6

20.17

20.01

nmol/l

0.68

14349

58383

(3000850) Epithelial cells [#/volume] in Urine

13116

53336

1.62

307.65

2.9

2.6

5.00

5.67

e6/l

7.23

12070

48215

(3048689) Calprotectin [Mass/mass] in Stool

8712

32135

1.74

307.65

2.3

2.5

130.06

132.97

ug/g

0.26

7038

25675

(3030467) Casts [#/volume] in Urine by Automated count

15395

69302

1.46

282.75

3.6

3.1

0.33

0.45

e6/l

10.08

11741

49306

(3007164) IgA [Mass/volume] in Serum or Plasma

11895

50914

1.51

280.38

1.5

1.4

2.38

2.40

g/l

0.27

7450

32438

(3017732) Neutrophils [#/volume] in Blood

7936

31003

1.62

279.09

3.0

3.2

4.53

4.50

e9/l

0.13

6950

26857

(36304419) Bacteria [Presence] in Urine

14732

66070

1.46

273.97

3.5

3.0

654.22

188.25

estimate

0.31

300

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5115

17813

1.79

273.41

3.0

2.9

148.13

220.71

ng/l

29.19

4685

16245

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11796

50630

1.50

273.22

1.7

55754931.27

31314256.08

pmol/l

2.92

10053

42304

(3047181) Lactate [Moles/volume] in Blood

2526

6813

2.27

273.18

5.6

5.7

1.28

1.35

mmol/l

2.62

2245

6014

(3033658) Prothrombin time (PT) actual/Normal

14443

64658

1.46

270.35

4.2

4.1

92.44

89.73

32.08

14021

63315

(3014051) Protein [Presence] in Urine by Test strip

16189

74495

1.42

258.90

3.1

2.7

0.10

0.08

0.22

248

1722

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9889

41366

1.52

256.21

3.2

3.5

0.82

mmol/l

0.33

9278

39062

(3014576) Chloride [Moles/volume] in Serum or Plasma

8310

33552

1.56

251.86

7.1

7.7

104.28

104.47

mmol/l

3.17

8305

33529

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

22180

108315

1.38

247.56

2.0

1.9

1.43

1.35

mmol/l

28.35

19130

91833

(3020891) Body temperature

3259

10101

1.98

247.22

4.7

4.6

36.91

36.90

°c

0.39

3245

9999

(3005322) IgE [Units/volume] in Serum or Plasma

4589

15939

1.78

246.05

1.4

1.3

188.58

268.64

u/ml

5.12

4297

14882

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4814

17092

1.75

239.21

1.7

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

10213

43646

1.49

236.27

2.6

13.47

13.27

umol/l

1.64

9518

40765

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

10914

47274

1.47

236.12

2.7

3.1

2.44

2.45

mmol/l

2.13

9735

42252

(3039000) Anion gap in Blood by calculation

1821

4542

2.44

233.32

6.4

7.0

11.11

11.42

mmol/l

3.03

1643

4093

(3018572) Chloride [Moles/volume] in Blood

1821

4542

2.44

233.32

6.4

7.0

105.00

105.11

mmol/l

0.41

1644

4094

(3030981) Hyaline casts [#/volume] in Urine by Automated count

5219

19094

1.70

232.75

2.5

2.4

0.38

0.41

e6/l

0.50

4934

18297

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

10062

43040

1.49

231.00

3.3

2.8

1.08

1.16

e6/l

0.39

5716

21740

(3000494) Fungus identified in Specimen by Culture

7500

30148

1.56

229.52

1.5

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

5143

18937

1.68

223.47

2.6

2.7

68.44

67.12

ml/min/173m2

1.48

2204

7795

(3020630) Protein [Mass/volume] in Serum or Plasma

5107

18872

1.68

218.68

2.5

2.6

66.78

66.25

g/l

5.34

4695

17363

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8892

37610

1.49

213.53

2.1

29.17

29.70

13.08

8620

36607

(3000475) Leukocytes [#/volume] in Synovial fluid

1937

5207

2.26

210.14

1.7

1.6

12136.22

14209.51

e6/l

1.14

1416

3679

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3214

10487

1.88

208.82

5.4

4.9

1.74

1.62

7.53

3024

9957

(3004789) Transferrin [Mass/volume] in Serum or Plasma

9446

40657

1.47

207.14

2.5

2.6

2.38

2.33

g/l

14.68

8752

37510

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

40876

223104

1.40

205.56

24.7

17.8

332.67

332.57

g/l

1.46

40706

221722

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3986

13976

1.76

205.26

9.1

10.5

16.38

16.07

7.51

3804

13501

(3023420) DNA double strand Ab [Units/volume] in Serum

3041

9801

1.90

204.93

1.6

1.9

6.20

8.19

iu/ml

3.10

730

2211

(3007930) Methemoglobin/Hemoglobin.total in Blood

2974

9566

1.90

201.51

5.6

5.1

0.90

0.87

3.70

2790

9055

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

4722

17576

1.66

195.49

3.5

4.1

84.28

93.72

ng/l

9.35

4195

15240

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

16756

80634

1.35

189.23

5.5

5.2

2.86

3.27

ug/l

0.77

15444

73098

(3005719) IgG [Mass/volume] in Serum or Plasma

4907

18675

1.62

185.72

2.7

2.8

10.36

10.77

g/l

8.12

4520

17284

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

13698

64018

1.37

185.69

4.7

4.2

21.98

22.05

0.20

6240

30216

(40760892) CBC W Ordered Manual Differential panel - Blood

12660

58520

1.38

183.12

4.7

4.5

—

8.64

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4464

16735

1.64

178.94

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

8620

37408

1.45

177.71

2.6

22.64

22.95

1.17

8013

34801

(3043409) Potassium [Moles/volume] in Arterial blood

1998

5838

2.08

176.29

4.4

4.6

3.86

3.89

mmol/l

1.98

1980

5784

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3402

11934

1.75

173.77

1.1

1.98

5.11

u/ml

0.82

139

(3018405) Lactate [Moles/volume] in Arterial blood

2281

7041

1.97

173.49

4.1

4.3

1.36

1.42

mmol/l

1.42

2238

6903

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6979

29281

1.48

170.24

2.7

2.8

6.90

9.28

umol/l

17.98

6056

25693

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2193

6733

1.98

169.25

1.5

1.4

277.27

267.37

ug/g

1.26

1301

3913

(3022145) Colonoscopy Study observation

6843

28772

1.48

164.66

1.4

—

(36660697) Celiac disease serology panel - Serum

5128

20303

1.56

163.26

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1948

5844

2.02

160.06

1.5

1.4

—

(3012544) pH of Venous blood

5979

24586

1.51

159.94

3.8

3.9

7.38

0.06

3320

14329

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4144

15731

1.62

157.08

9.0

10.6

1.41

1.30

9.60

4108

15634

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2260

7200

1.91

156.63

1.3

32.28

42.26

u/ml

0.78

412

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7546

32624

1.44

156.51

5.3

6.3

1.03

1.04

mmol/l

0.67

7018

30441

(3014007) Fractional oxyhemoglobin in Arterial blood

4132

15748

1.61

153.98

9.1

10.7

93.88

93.94

0.22

4122

15697

(4024509) Urine culture

2916

10129

1.76

153.47

2.0

1.8

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1898

5796

1.99

148.39

1.3

550.89

556.23

mg/l

0.07

1815

5553

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5811

24207

1.48

144.90

3.7

3.9

5.84

5.80

kpa

3.36

5659

23597

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3975

15304

1.59

141.53

9.3

10.9

0.67

0.63

8.24

3947

15218

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2091

6713

1.89

141.38

1.3

7.11

8.05

u/ml

0.26

280

983

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2074

6642

1.90

141.27

1.3

—

(3002032) Base excess in Venous blood by calculation

5659

23581

1.48

140.59

3.8

3.9

1.87

1.69

mmol/l

3.33

4984

20616

(3027945) Reticulocytes/Erythrocytes in Blood

6552

28110

1.44

140.11

2.4

2.6

1.77

1.76

0.18

5848

25075

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1877

5829

1.95

139.86

1.3

25.47

17.77

u/ml

0.28

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2091

6739

1.88

139.72

1.3

8.80

5.18

u/ml

0.55

182

634

(3041096) Erythrocytes [Presence] in Urine by Automated

15364

75588

1.30

137.00

3.5

3.0

0.25

0.23

estimate

0.06

4160

22293

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3300

12230

1.65

136.76

3.1

2.9

1.37

1.23

8.96

3282

12177

(3026782) Osmolality of Urine

10174

47267

1.35

135.53

3.1

2.8

528.68

538.73

mosm/kgh2o

4.31

9016

41290

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

39836

220700

1.31

134.27

22.1

17.5

13.63

13.56

24.78

39508

217467

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1687

5132

1.99

133.13

1.2

3.74

3.76

mmol/l

0.28

1586

4869

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3251

12131

1.64

130.99

3.1

2.9

0.62

0.63

0.54

3240

12095

(3023520) Reticulocytes [#/volume] in Blood

5121

21200

1.49

130.77

2.3

2.6

69.77

69.14

e9/l

0.57

3868

15324

(3014111) Lactate [Moles/volume] in Serum or Plasma

5307

22178

1.47

129.21

7.4

8.2

1.32

1.36

mmol/l

1.94

5212

21739

(3024354) Oxygen [Partial pressure] in Venous blood

4836

19908

1.49

126.68

3.3

3.2

4.48

4.60

kpa

3.43

4711

19344

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1780

5631

1.91

125.54

1.3

1.2

1.92

5.49

u/ml

2.50

376

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2857

10425

1.67

125.30

2.0

2.1

40.14

39.60

u/l

0.69

2569

9327

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1666

5158

1.95

125.06

1.4

1.5

1632.38

1965.79

e6/l

0.18

1395

3982

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

579

1087

3.20

123.82

1.5

1.4

5.54

6.88

u/l

1.13

497

933

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1644

5114

1.94

121.72

1.3

1.4

25.36

38.42

e6/l

0.76

1312

3720

(3025941) Bacteria identified in Stool by Culture

3521

13635

1.58

121.58

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1322

15006

0.51

120.02

1.5

1.6

915.14

1032.40

mu/l

4.27

1056

12513

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2193

7527

1.77

119.53

1.6

1.8

1.21

1.18

g/l

4.54

2083

7216

(3045424) Erythrocytes [Presence] in Urine

3055

11499

1.62

118.54

2.2

2.0

0.01

0.11

estimate

0.78

872

3630

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2139

7323

1.77

117.56

1.6

1.8

0.23

0.24

g/l

0.12

2023

6988

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1677

5319

1.91

117.28

1.3

1.2

50.63

45.46

u/ml

0.45

148

473

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3044

11513

1.61

115.75

3.9

4.0

49.44

46.93

6.30

3009

11352

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2375

8429

1.71

115.14

2.1

2.3

428.32

635.13

ug/l

2.49

2244

7984

(4034850) Laboratory test

2016

6836

1.79

114.35

11.3

9.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1882

6270

1.82

113.06

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3879

15605

1.52

112.70

3.6

3.5

5.17

5.12

kpa

3.33

3662

14880

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8694

40409

1.34

112.60

3.5

2.9

3.04

2.69

e6/l

1.75

4369

18993

(42529406) Shigella sp [Presence] in Stool by Culture

1884

6287

1.81

112.57

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1874

6246

1.82

112.42

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

5550

23985

1.42

112.11

2.7

2.5

46.97

46.79

u/l

0.01

4676

20503

(3019225) pH of Specimen

5289

22665

1.43

111.88

4.0

7.35

7.36

2.56

3877

16238

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2516

9189

1.66

109.61

2.3

2.2

7.33

7.34

g/l

0.20

2307

8359

(3022621) pH of Urine by Test strip

4719

19867

1.46

109.52

2.8

2.4

6.04

6.09

2.48

3122

12914

(3009343) pH of Capillary blood

3767

15161

1.52

109.08

3.5

7.41

7.42

1.16

3154

12591

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2511

9179

1.66

109.01

2.3

2.2

4.26

4.21

g/l

1.43

2308

8360

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2507

9163

1.66

108.89

2.3

2.2

3.66

3.77

g/l

2.23

2306

8344

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1438

4439

1.96

108.73

1.7

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3672

14735

1.52

107.75

1.8

1.9

1.28

1.33

g/l

0.57

3391

13609

(3004119) Hemoglobin [Mass/volume] in Venous blood

3705

14900

1.52

107.61

3.5

3.3

130.41

129.37

g/l

1.89

3573

14535

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4004

16404

1.49

106.41

3.2

3.6

4.49

4.51

pmol/l

0.70

3582

14872

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2388

8672

1.67

106.23

2.3

2.2

2.78

2.92

g/l

9.16

2185

7844

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2712

10218

1.61

104.45

1.4

1.6

12.47

15.08

iu/ml

0.31

322

(3010144) Erythrocytes [#/volume] in Synovial fluid

776

1891

2.47

103.98

1.4

91173.19

119966.19

e6/l

0.55

496

1232

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7272

33330

1.35

102.28

2.0

1.8

1.51

1.42

17.97

6398

29690

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3312

13172

1.53

101.02

3.4

3.3

1.66

1.72

mmol/l

0.38

2432

9612

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2179

7881

1.68

98.28

2.8

2.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2347

8707

1.63

95.98

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

6418

29144

1.36

95.26

4.0

4.6

237.38

244.49

u/l

2.70

6053

27787

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2168

7941

1.65

93.12

2.3

2.2

9.77

10.36

g/l

7.11

1936

7041

(3026389) Candida sp identified in Specimen by Organism specific culture

1139

3422

2.00

92.83

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1789

6305

1.71

88.58

1.2

3.35

3.81

1.87

217

1084

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1170

3641

1.94

86.36

1.4

1.5

15.27

14.18

u/ml

0.06

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2160

8056

1.62

86.33

3.7

24.86

24.78

mmol/l

0.59

1982

7403

(3045716) Anion gap in Serum or Plasma by calculation

849

2344

2.18

86.04

3.6

3.0

10.73

10.88

mmol/l

0.49

841

2314

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2133

7946

1.62

85.64

2.4

2.3

0.78

g/l

0.01

1867

6808

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1085

3304

1.98

85.19

1.2

13.37

17.38

u/ml

0.33

138

(3021788) Differential panel - Synovial fluid

1279

4128

1.87

84.70

1.6

1.5

1.00

0.94

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

680

8576

0.47

83.92

1.5

59.14

62.37

ug/l

0.57

527

7058

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

635

8179

0.46

83.08

1.4

1.5

1.14

1.16

ratio

0.24

354

4884

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

639

8206

0.46

82.92

1.4

1.5

1.12

1.19

ratio

1.12

360

4947

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

639

8205

0.46

82.89

1.4

1.5

0.95

ratio

0.02

358

4909

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

628

8095

0.46

82.33

1.4

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3355

13942

1.46

82.20

4.0

4.1

24.41

24.11

mmol/l

6.73

3318

13733

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

538

1232

2.62

81.70

1.1

2.79

7.30

nmol/l

1.67

247

(3017446) Testosterone [Moles/volume] in Serum or Plasma

5154

23150

1.36

81.05

2.6

2.3

13.02

13.07

nmol/l

0.20

4642

21193

(3027273) Bicarbonate [Moles/volume] in Venous blood

2698

10751

1.52

81.05

3.2

3.5

25.25

25.17

mmol/l

0.52

2575

10416

(3020961) Endomysium IgA Ab [Titer] in Serum

2897

11720

1.50

81.04

1.1

163.57

204.46

titre

0.42

350

(3021589) Normoblasts [#/volume] in Blood

21779

116269

1.20

78.36

11.8

10.8

0.00

e9/l

0.07

17936

94284

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1850

6798

1.64

78.30

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2053

7748

1.60

78.10

1.5

1.6

13.89

4.82

iu/ml

0.46

373

1343

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2693

10837

1.51

77.17

1.8

1.7

0.33

0.31

mg/l

0.56

1355

5247

(3043238) Trisomy 21 risk [Likelihood] in Fetus

522

7024

0.44

76.74

1.5

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5320

24236

1.34

76.00

2.3

0.22

0.21

g/l

9.00

4937

22644

(3047352) Trisomy 18 risk [Likelihood] in Fetus

507

6871

0.43

75.94

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3163

13205

1.45

75.46

1.1

—

(3005033) Fetal Nuchal fold Thickness US

499

6781

0.43

75.26

1.4

1.5

1.24

1.26

0.25

329

4942

(3006571) Granulocytes/Leukocytes in Synovial fluid

874

2583

2.03

74.49

1.5

1.6

55.91

57.30

0.40

533

1672

(3004716) Salmonella sp identified in Stool by Organism specific culture

2906

12012

1.47

72.89

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6384

30064

1.30

71.90

1.6

1.7

4.52

6.82

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

671

1815

2.22

71.48

1.1

39.26

46.13

mg/l

2.33

579

1525

(3039162) Centromere protein B Ab [Units/volume] in Serum

944

2917

1.95

71.13

1.3

45.97

55.95

u/ml

0.45

161

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2363

9407

1.52

71.11

2.0

1.9

2.21

2.29

ug/l

0.09

2068

8348

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

651

1743

2.24

71.04

1.1

268.34

268.58

mg/l

0.01

584

1539

(3004616) Nuclear Ab [Presence] in Serum

953

2977

1.92

69.59

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3452

14863

1.41

69.45

9.2

10.4

24.36

24.19

mmol/l

2.36

3378

14512

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

819

2426

2.03

69.40

1.1

87.00

19.38

au/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

921

9913

0.55

69.10

1.5

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1969

7574

1.57

69.04

3.2

3.1

34.11

44.96

mg/l

3.98

1730

6415

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1798

6773

1.60

68.83

1.1

4.28

5.89

eliau/ml

1.24

196

970

(3034860) Kappa light chains.free [Mass/volume] in Serum

1970

7586

1.57

68.75

3.2

3.1

64.84

56.40

mg/l

0.17

1732

6423

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1784

6714

1.60

68.56

2.1

1.8

198.94

202.75

pmol/l

0.78

1682

6422

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1031

3342

1.85

67.37

1.3

0.19

0.27

nmol/l

0.73

213

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

797

2364

2.02

67.30

1.1

37.71

82.51

au/ml

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1794

6825

1.59

65.90

2.2

0.02

0.03

g/l

0.48

1643

6098

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1494

5448

1.65

65.05

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

612

1659

2.21

64.91

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1009

3296

1.84

64.37

1.3

0.59

2.06

nmol/l

1.37

972

3194

(4094501) Cardiovascular stress test using bicycle ergometer

1773

6764

1.58

64.35

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1719

6510

1.59

64.34

2.2

0.00

g/l

0.01

1530

5693

(3017315) Amylase [Enzymatic activity/volume] in Urine

448

1058

2.54

64.16

1.3

1.2

276.20

402.80

u/l

1.27

414

986

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

420

960

2.62

64.13

1.8

1.9

111.82

135.40

umol/l

0.85

221

459

(3024980) IgG subclass 4 [Mass/volume] in Serum

1181

4062

1.75

63.60

1.6

0.70

0.81

g/l

3.26

896

3157

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1286

4534

1.71

63.48

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

737

2173

2.04

63.26

1.1

—

(4062490) Immunoglobulin typing, IgG

780

2369

1.98

61.75

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1646

6236

1.59

61.49

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

563

1510

2.23

61.26

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

936

3037

1.85

61.00

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

797

2450

1.95

60.99

1.2

56.64

44.13

u/ml

0.61

125

(44790049) Parainfluenza type 3 nucleic acid detection

936

3038

1.85

60.93

1.5

—

(3037756) Immunofixation for Serum or Plasma

1281

4565

1.69

60.81

1.7

—

(44790048) Parainfluenza type 2 nucleic acid detection

936

3041

1.85

60.75

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

936

3042

1.85

60.69

1.5

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2229

9058

1.49

60.65

2.1

1.8

39.44

41.38

nmol/l

3.54

2182

8890

(3024139) IgG subclass 3 [Mass/volume] in Serum

787

2417

1.95

60.39

1.4

0.40

0.42

g/l

0.39

578

1696

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1234

4361

1.70

60.39

1.2

1.3

85.88

119.59

titre

0.67

(3028192) IgG subclass 2 [Mass/volume] in Serum

787

2419

1.95

60.25

1.4

2.94

3.05

g/l

0.88

573

1702

(3027135) IgG subclass 1 [Mass/volume] in Serum

787

2421

1.95

60.11

1.4

6.57

6.95

g/l

1.82

574

1702

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1612

6115

1.59

59.89

2.3

2.2

0.00

g/l

-0.00

1523

5684

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

959

3165

1.82

59.24

6.7

6.0

11.88

11.44

mg/l

2.15

906

2927

(4027681) Cerebrospinal fluid IgG ratio and IgG index

513

1342

2.29

59.14

1.2

1.3

0.57

0.72

ratio

1.87

329

722

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1220

4323

1.70

59.13

1.2

1.3

270.55

324.36

titre

0.38

318

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

553

1497

2.21

58.89

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4105

18670

1.34

58.43

1.2

127.42

150.39

u/ml

3.11

1651

7106

(3023419) Bacteria identified in Sputum by Culture

879

2844

1.86

57.80

2.7

2.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2327

9655

1.46

56.96

1.6

1.7

16.34

16.70

u/ml

0.07

478

2628

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1722

6728

1.54

56.29

2.1

2.2

11.45

mg/l

0.01

1614

6342

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2065

8422

1.48

55.13

2.7

2.8

24.72

24.58

mmol/l

0.96

2036

8259

(3020779) Urea [Moles/volume] in Serum or Plasma

4851

22798

1.29

54.40

6.8

7.8

9.45

10.00

mmol/l

5.97

4631

21763

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

473

1242

2.28

54.12

1.1

1.07

1.11

u/l

0.32

197

492

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

836

2733

1.84

53.26

2.1

2.0

24.50

26.84

mg/l

0.57

296

1028

(3019420) Tryptase [Mass/volume] in Serum or Plasma

489

1319

2.22

52.58

1.6

1.5

8.55

7.87

ug/l

0.28

459

1203

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1230

4508

1.64

52.51

1.4

—

(3017181) Myelocytes/Leukocytes in Blood

4755

22417

1.29

51.92

4.3

4.4

0.95

0.97

0.15

1500

6687

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

856

2849

1.80

51.50

1.3

0.19

0.30

nmol/l

0.68

653

2250

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1703

6775

1.51

51.23

3.1

2.34

4.48

ratio

4.07

1039

3825

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

675

2084

1.94

51.09

1.2

72.65

66.89

u/ml

0.15

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

294

4206

0.41

50.51

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1563

6129

1.54

50.24

1.5

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1968

8099

1.47

50.17

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2241

9453

1.43

50.16

2.1

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1175

4312

1.64

49.92

2.0

1.9

5.20

5.26

mmol/24h

0.25

1041

3877

(40757494) Bilirubin.total [Moles/volume] in Blood

391

990

2.36

48.57

2.0

2.1

16.78

24.55

umol/l

0.86

(3002179) Metamyelocytes/Leukocytes in Blood

4504

21274

1.29

48.27

4.1

4.3

0.68

0.73

0.49

1433

6344

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

340

808

2.52

48.24

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

585

1764

1.99

47.37

1.2

57.20

46.75

u/ml

0.31

108

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1239

4671

1.59

47.23

1.7

1.6

—

(3044927) Protein electrophoresis panel - Urine

634

1972

1.93

47.01

1.2

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

627

1943

1.93

47.00

1.5

1.6

31.24

31.81

0.13

383

1235

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

248

505

2.94

46.82

1.3

1.2

38.55

40.82

0.31

146

348

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6126

30128

1.24

46.53

5.3

4.6

31.75

32.22

2.63

4369

20606

(3025577) Chromium [Mass/volume] in Blood

399

1041

2.29

46.41

2.3

2.2

2.30

2.34

ug/l

0.07

338

864

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2047

8614

1.43

46.38

2.0

1.8

—

(3026470) Cobalt [Mass/volume] in Blood

406

1069

2.27

46.25

2.3

2.2

3.57

ug/l

0.00

371

997

(3020191) Ethanol [Moles/volume] in Serum or Plasma

649

2047

1.90

46.20

1.6

1.4

1.28

1.27

promille

0.07

531

1653

(21494755) Public health laboratory ask at order entry panel

4137

30878

0.78

45.79

1.4

1.3

—

(40768443) Skin Pathology biopsy report

2595

11407

1.37

45.69

1.2

—

(3025159) Blasts/Leukocytes in Blood

4540

21630

1.27

45.28

4.6

0.27

0.30

0.11

1210

5503

(40760888) Immunoglobulin light chains.free panel - Serum

1285

4936

1.56

45.26

3.2

0.82

0.90

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

700

2279

1.84

45.24

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

702

2296

1.83

44.73

1.4

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

1625

6608

1.48

43.96

3.2

1.84

2.29

index

1.59

822

3380

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2601

11509

1.36

43.92

1.6

1.8

1.57

1.51

g/l

2.72

2254

9889

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

984

3571

1.65

43.69

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

730

2442

1.79

43.27

1.3

1.2

28.36

28.22

nmol/l

0.01

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

403

1100

2.19

42.25

1.3

66.22

59.35

0.66

140

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

866

3083

1.69

41.35

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

4465

21513

1.26

40.32

4.4

0.13

0.11

0.58

1213

5820

(21494890) Protein electrophoresis panel - 24 hour Urine

658

2185

1.80

40.00

2.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

844

3017

1.68

39.71

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1079

4116

1.57

39.19

1.4

1.3

27.82

26.70

u/l

0.49

860

3398

(3011985) Renin [Units/volume] in Plasma

964

3585

1.61

38.92

1.6

69.79

64.20

mu/l

0.26

867

3254

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

840

3017

1.67

38.84

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

1715

7228

1.43

38.50

1.2

1133.68

933.74

titre

0.47

214

(3024263) Appearance of Synovial fluid

368

1006

2.19

38.50

1.6

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3463

16269

1.29

38.36

7.8

8.4

24.90

24.64

mmol/l

4.56

3438

16136

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

750

7291

0.61

38.02

1.5

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1669

7020

1.43

37.88

1.5

11.81

13.41

iu/ml

0.23

162

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1065

4087

1.56

37.71

1.1

1.2

0.94

1.09

0.23

202

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

202

416

2.90

37.54

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

617

2053

1.80

37.30

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

1738

7392

1.41

37.09

1.2

122.96

109.63

titre

0.18

179

697

(3019832) Treponema pallidum Ab [Presence] in Serum

4149

30268

0.80

37.07

1.7

1.8

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

235

534

2.63

36.56

1.4

1.5

52.24

55.54

0.56

194

464

(3017143) Hepatitis C virus Ab [Presence] in Serum

6385

32274

1.20

36.26

1.6

1.7

—

(3017704) Immunofixation for Urine

390

1120

2.08

36.13

1.7

1.6

—

(3003129) Base excess in Capillary blood by calculation

771

2770

1.67

35.65

2.2

2.1

0.47

0.39

mmol/l

0.22

747

2649

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

253

605

2.50

35.61

1.2

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1896

8251

1.38

35.41

1.4

10.42

9.83

u/l

1.02

1551

6702

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

283

716

2.36

35.39

2.2

2.0

54.96

54.48

ug/l

0.05

276

702

(3005988) Vibrio sp identified in Specimen by Organism specific culture

792

2873

1.65

35.31

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

907

3409

1.60

35.10

1.1

2.85

2.81

0.03

136

666

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

790

2871

1.65

34.98

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

788

2870

1.65

34.60

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

313

840

2.23

34.28

1.2

0.30

g/l

0.30

255

662

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

817

3011

1.63

34.25

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

596

2015

1.77

34.22

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

284

732

2.32

34.12

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

556

1850

1.80

33.67

1.2

1.3

1.98

2.19

mmol/l

3.34

513

1723

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

880

3323

1.59

33.43

1.4

306.73

393.66

pmol/l

1.23

767

2856

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

400

1195

2.00

33.41

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

810

3001

1.62

33.27

1.7

349.69

383.13

mu/l

0.89

658

2426

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4926

34949

0.82

33.24

2.0

1.9

3.58

3.50

ratio

2.90

3781

26664

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

556

1859

1.79

33.15

1.4

1.3

1.88

1.83

u/ml

0.04

367

1030

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

496

1601

1.85

33.09

2.8

3.9

144.59

143.36

nmol/l

0.02

486

1574

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

255

638

2.39

32.72

1.2

1.3

134.52

128.67

nmol/l

0.21

205

439

(3027923) C peptide [Moles/volume] in Serum or Plasma

446

1400

1.91

32.39

1.6

1.22

1.30

nmol/l

0.85

343

1070

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

499

1627

1.84

32.27

1.5

27.19

26.61

u/ml

0.06

313

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

9287

48915

1.16

31.83

3.1

0.70

0.80

ug/l

13.55

5950

30569

(3047007) Chlamydophila sp Ab [Presence] in Serum

938

3642

1.54

31.62

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

666

2388

1.67

31.10

1.6

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

292

795

2.20

30.97

1.2

107.99

110.92

0.96

258

718

(3024928) Oxygen saturation in Venous blood

1460

6219

1.41

30.92

3.6

3.1

61.86

62.62

0.60

1402

5988

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1074

4316

1.49

30.86

1.1

16.52

14.58

au/ml

0.37

246

1289

(3003181) Sodium [Moles/volume] in Urine

1043

4172

1.50

30.65

1.4

62.48

61.75

mmol/l

0.20

836

3264

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1664

7258

1.38

30.65

1.9

2.0

7.81

11.55

iu/l

0.30

687

3042

(3017817) Protein [Mass] in Urine collected for unspecified duration

586

2046

1.71

30.18

2.6

2.5

849.25

1223.71

5.71

580

2021

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

573

1989

1.72

30.12

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

537

5343

0.59

30.00

1.5

59.81

60.39

ug/l

0.09

537

5343

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

573

1992

1.72

29.97

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

700

2574

1.63

29.68

1.3

74.27

53.41

u/ml

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

104

161

3.85

29.68

1.0

0.03

u/ml

0.37

104

161

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

374

1146

1.95

29.19

1.6

17.57

6.01

nmol/l

0.39

313

959

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3635

26248

0.81

29.05

1.7

1.6

3.50

mmol/l

0.00

2501

17805

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

530

1830

1.73

28.42

2.0

2.2

17.94

18.02

nmol/l

0.08

499

1724

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

273

752

2.17

28.21

1.9

2.1

8.35

9.20

mg/l

1.79

226

627

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

142

2144

0.39

28.02

20.0

20.9

1318.83

2906.91

nmol/l

1.10

135

2068

(3028717) Thiamine [Mass/volume] in Blood

146

297

2.93

27.86

1.2

63.72

64.26

ug/l

0.10

146

297

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

331

990

2.00

27.67

2.0

2.8

92.96

203.37

ug/l

0.46

322

945

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

550

1936

1.70

27.56

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

181

420

2.57

27.20

1.3

1.2

0.77

96.47

mg/l

2.94

131

306

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

133

2033

0.39

27.04

15.9

15.4

800.87

1950.04

nmol/l

0.82

128

1972

(3033923) Metanephrine [Moles/time] in 24 hour Urine

168

379

2.65

26.67

1.1

0.64

4.17

umol/24h

0.51

204

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

606

2210

1.64

26.61

1.6

1.7

—

(44813793) Dust mix specific IgE antibody measurement

475

1622

1.75

26.51

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

282

808

2.09

26.45

1.4

1.5

78.27

213.42

nmol/24h

2.32

282

808

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4861

24622

1.19

26.44

3.4

3.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

544

1942

1.68

25.92

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1268

5441

1.40

25.79

2.6

2.7

32.94

34.19

umol/l

0.89

1150

4938

(3037121) Protein [Mass/volume] in Urine

1840

8378

1.32

25.60

2.9

3.4

360.37

524.18

mg/l

1.18

763

4003

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

426

1424

1.79

25.56

1.4

1.3

713.87

486.12

titre

0.36

103

(3000330) Specific gravity of Urine by Test strip

2521

11989

1.27

25.12

3.6

3.2

1.02

ratio

2.58

2286

10732

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

472

1637

1.72

25.00

2.5

2.6

232.63

238.06

e6/l

0.22

418

1377

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1510

11910

0.75

24.97

1.1

0.65

0.63

ratio

0.70

180

1406

(3000034) Microalbumin [Mass/volume] in Urine

541

1952

1.66

24.79

2.9

3.0

43.98

52.65

mg/l

0.38

380

1400

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

413

1385

1.78

24.55

1.4

1.3

50.33

87.40

titre

1.12

100

(3018333) Ribosomal P Ab [Presence] in Serum

526

1898

1.66

24.12

1.2

—

(3023410) Appearance of Cerebral spinal fluid

643

2444

1.57

23.92

1.4

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

373

1223

1.82

23.87

1.1

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1333

5844

1.37

23.85

2.8

3.0

8.20

8.19

kpa

0.05

1306

5694

(3023323) Follitropin [Units/volume] in Serum or Plasma

3151

15461

1.23

23.73

1.4

1.3

28.35

26.96

iu/l

1.49

2734

13327

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

508

1826

1.66

23.65

1.1

9.38

7.70

iu/ml

0.66

133

544

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1120

4778

1.41

23.60

1.4

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1249

5428

1.38

23.59

1.5

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

220

600

2.19

23.40

1.3

1.2

41.11

40.13

g/l

0.39

108

320

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1118

4778

1.40

23.32

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5090

26165

1.18

23.17

3.4

4.6

23.90

27.27

ug/l

0.21

4121

21009

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

243

696

2.09

22.90

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1006

4240

1.42

22.71

1.3

34.23

32.29

u/l

0.14

896

3677

(3020717) Zinc [Moles/volume] in Serum or Plasma

390

1322

1.76

22.42

1.6

1.4

19.15

23.99

umol/l

2.97

364

1222

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

294

913

1.92

22.24

1.1

250.12

385.58

ng/l

0.29

277

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

520

1915

1.62

22.08

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

520

1915

1.62

22.08

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

520

1915

1.62

22.08

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1359

6052

1.35

22.03

2.2

132.15

130.82

g/l

1.08

1020

4645

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

263

799

1.97

21.21

1.6

1.4

14.68

14.84

pmol/l

0.14

214

687

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1261

5591

1.35

21.05

2.2

2.4

103.25

110.96

ug/min

0.23

732

3381

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

445

1598

1.66

20.86

2.4

2.5

531.58

553.50

e6/l

0.28

377

1276

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

252

763

1.97

20.54

3.5

3.0

4.94

4.89

kpa

0.31

252

763

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

251

764

1.96

20.16

3.5

3.0

10.72

10.35

kpa

0.95

251

764

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

460

4312

0.63

20.08

1.3

1.4

3.74

3.42

ug/l

0.15

377

3874

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1545

7106

1.30

20.04

1.8

1.7

—

(3017354) Segmented neutrophils/Leukocytes in Blood

648

2573

1.51

19.91

3.1

3.4

57.22

57.59

0.16

565

2208

(40762814) Titanium [Mass/volume] in Blood

128

294

2.60

19.78

2.4

2.5

4.01

3.55

ug/l

0.25

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

688

2792

1.47

19.04

2.9

3.6

15.46

7.46

nmol/l

0.45

664

2714

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.70

18.94

1.7

247.19

256.36

nmol/l

0.03

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

113

249

2.71

18.91

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

144

359

2.39

18.88

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

624

2489

1.50

18.80

1.5

1.3

1.57

1.41

nmol/l

2.62

580

2233

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

411

1491

1.65

18.61

1.0

780.24

728.64

ng/l

1.22

288

1078

(3042111) Morphology [Interpretation] in Bone marrow Narrative

896

3836

1.40

18.60

1.7

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

194

556

2.08

18.38

1.7

1.6

112.62

135.29

au/ml

0.27

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

411

1496

1.64

18.38

1.0

42.11

42.26

ng/l

0.01

290

1109

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

183

2137

0.51

18.25

1.4

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

408

1485

1.64

18.25

1.0

275.58

366.30

ng/l

2.88

297

1113

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

718

2966

1.45

18.17

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1083

4803

1.35

18.12

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

545

2133

1.53

17.97

2.6

2.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

207

615

2.01

17.85

1.7

1.6

9.61

9.25

ug/l

0.44

207

615

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

406

1488

1.63

17.69

2.1

2.8

655.55

1094.84

u/ml

5.54

399

1469

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

295

990

1.78

17.67

1.5

1.6

29.54

28.91

umol/l

0.44

275

925

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

328

1136

1.72

17.65

1.1

—

(3008295) Osmolality of Serum or Plasma

627

2538

1.48

17.62

1.4

1.5

276.67

279.80

mosm/kgh2o

2.64

471

1989

(3021901) Oxygen saturation in Capillary blood

1139

5114

1.33

17.57

2.8

3.0

90.39

90.18

0.50

1110

4961

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

192

563

2.04

17.18

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

333

1168

1.70

17.14

1.3

1.2

158.43

163.35

mmol/24h

0.45

333

1168

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

394

1448

1.63

17.01

1.3

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.96

16.99

1.9

1.6

141.68

210.59

nmol/l

0.84

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

189

555

2.03

16.85

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

147

390

2.25

16.85

6.6

10.56

10.79

0.48

147

390

(3020876) Protein [Mass/time] in 24 hour Urine

707

2956

1.43

16.82

2.3

2.5

1.18

1.30

g/24h

0.49

368

1818

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

524

2065

1.52

16.78

1.3

1.2

109.07

110.96

pmol/l

0.37

524

2065

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1746

12852

0.80

16.56

1.2

0.90

0.89

g/l

1.88

1738

12818

(3009015) Lactate [Moles/volume] in Synovial fluid

189

2.84

16.48

1.3

1.2

5.57

6.76

mmol/l

0.83

(3001186) Copper [Moles/volume] in Serum or Plasma

211

651

1.94

16.43

1.4

1.3

16.34

16.90

umol/l

0.88

187

556

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

502

1972

1.52

16.33

1.2

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

396

1477

1.60

16.14

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

645

2674

1.44

16.09

1.1

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

887

3887

1.37

16.07

3.0

2.5

13.25

13.14

2.80

880

3828

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

197

599

1.96

16.00

9.5

8.1

6.07

5.93

kpa

1.43

178

525

(3034891) Synovial lining cells/cells in Synovial fluid

300

1044

1.72

15.93

1.5

3.98

3.72

0.09

242

(42529582) MDA5 Ab [Presence] in Serum by Line blot

199

609

1.95

15.88

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

199

609

1.95

15.88

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

199

609

1.95

15.88

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

199

609

1.95

15.88

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

359

1315

1.63

15.75

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

178

525

2.02

15.73

9.9

7.9

5.58

5.73

kpa

0.31

178

525

(4146454) Self-monitoring of blood glucose

624

2584

1.44

15.67

2.7

2.8

—

(3011412) CD3 cells [#/volume] in Blood

571

2330

1.47

15.49

2.3

2.4

1281.43

1196.77

e6/l

0.84

507

2051

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

350

1285

1.63

15.24

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

632

2639

1.43

15.20

1.1

1.66

2.07

iu/ml

0.30

(3006576) Bicarbonate [Moles/volume] in Blood

233

764

1.82

15.14

6.1

6.2

25.31

24.95

mmol/l

0.65

213

686

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

137

3.09

15.01

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

837

3677

1.36

14.97

1.1

1.49

1.51

g/l

0.63

761

3384

(3035947) Staphylolysin Ab [Units/volume] in Serum

303

1079

1.68

14.84

1.2

1.1

3.48

4.36

iu/ml

0.71

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1686

8145

1.24

14.73

3.0

0.34

0.35

iu/ml

0.09

941

4392

(3004451) EKG impression Narrative

331

1213

1.63

14.54

1.4

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

215

697

1.84

14.51

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1502

7196

1.25

14.15

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

172

523

1.96

14.05

2.3

2.9

860.21

385.23

ug/l

0.33

172

523

(3040151) Glucose [Moles/volume] in Capillary blood

658

2809

1.40

14.03

5.2

6.3

7.35

7.42

mmol/l

0.10

529

2315

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

494

2007

1.47

13.76

1.1

285.39

435.82

mg/l

0.53

449

1845

(3042517) Benzodiazepines panel - Urine

107

271

2.36

13.71

3.3

3.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.62

13.67

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1000

4581

1.31

13.51

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

996

4562

1.31

13.47

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

184

2.66

13.42

1.7

1.73

1.76

mg/l

0.06

154

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

284

1023

1.66

13.39

2.3

—

(4015189) Microbial culture of sputum

166

508

1.95

13.34

2.4

2.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.55

13.03

1.1

1.0

0.09

0.07

u/ml

0.19

(3002256) Pathology report gross observation

6576

35666

1.11

13.02

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

910

4141

1.31

12.92

1.6

1.7

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

162

1760

0.55

12.91

1.4

30.46

34.78

nmol/l

0.90

139

1625

(3036489) Thrombin time

2033

10152

1.20

12.84

1.9

2.0

20.81

21.05

0.82

1752

8964

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

125

349

2.14

12.83

2.0

—

(3004809) Band form neutrophils/Leukocytes in Blood

895

4069

1.32

12.80

3.2

3.4

1.26

1.58

2.17

805

3645

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

539

2265

1.42

12.62

3.7

3.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1240

5906

1.26

12.35

1.1

1.31

2.01

u/ml

2.68

686

3039

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.61

12.28

1.1

1.0

0.07

0.05

u/ml

0.18

(3018851) Theophylline [Moles/volume] in Serum or Plasma

155

2.73

12.26

2.2

1.8

51.42

46.57

umol/l

0.58

155

(3021387) Prolactin [Units/volume] in Serum or Plasma

2055

10318

1.19

12.24

1.7

281.76

306.87

mu/l

2.06

1891

9357

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

159

495

1.92

12.22

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

288

1068

1.61

12.17

1.6

1.7

2.11

1.96

umol/l

2.41

256

980

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

248

885

1.67

12.17

2.3

1.8

29.94

30.06

0.04

233

837

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

163

513

1.90

12.13

1.7

1.6

0.39

0.41

ug/l

0.19

121

359

(3011048) Pyruvate [Moles/volume] in Blood

3.22

12.05

1.5

1.3

71.98

81.04

umol/l

0.87

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.88

12.04

1.1

1.0

0.03

0.04

u/ml

0.86

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1859

9271

1.20

11.93

2.8

3.9

616.05

2089.20

u/ml

1.35

1590

8046

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1113

5266

1.26

11.75

2.0

2.2

0.89

0.86

nmol/l

0.54

968

4458

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

320

1229

1.55

11.70

1.2

9.53

9.99

mm/h

0.31

320

1229

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

191

2.50

11.67

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

960

4464

1.29

11.66

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

235

846

1.66

11.20

2.0

2.1

40.43

40.33

g/l

0.09

235

846

(3033099) Centromere Ab [Titer] in Serum

179

597

1.79

11.17

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

312

1207

1.54

11.08

1.4

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1155

5528

1.25

11.08

5.6

5.9

4889.45

1106.98

iu/ml

0.52

178

834

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

401

1640

1.46

10.93

1.1

6.18

1.07

0.46

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

252

931

1.62

10.88

1.1

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

964

4528

1.27

10.84

3.5

3.2

0.80

nmol/l

0.03

785

3627

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3675

19475

1.13

10.77

3.7

3.9

1.23

mmol/l

1.22

3201

16800

(3002619) Bacteria identified in Specimen by Culture

175

588

1.78

10.68

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

672

3015

1.33

10.64

1.5

—

(4195642) Thrombophilia screening test

852

3954

1.29

10.56

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

537

0.28

10.53

1.2

66.76

68.72

ug/l

0.07

537

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.17

10.53

1.5

1.3

1.99

1.87

g/l

0.17

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

153

496

1.84

10.49

1.2

305.37

329.12

pmol/l

0.21

113

385

(3011436) Histone Ab [Units/volume] in Serum

145

462

1.87

10.48

1.1

—

27.86

—

(3006245) CD3-CD19+ cells/cells in Blood

251

936

1.60

10.46

2.3

2.0

7.74

9.51

1.81

230

868

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

126

383

1.96

10.44

1.1

—

(3014271) Vancomycin [Susceptibility]

273

1039

1.57

10.44

3.1

2.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

137

431

1.90

10.30

1.3

1.1

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

4.15

10.24

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

352

1423

1.48

10.21

1.4

1.2

4.40

5.13

umol/l

1.50

301

1260

(3016038) Potassium [Moles/volume] in Urine

374

1536

1.45

10.03

1.2

32.97

34.55

mmol/l

0.75

323

1359

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

3.29

9.93

1.4

1.3

1.61

1.75

mg/l

0.27

(3032057) Clostridioides difficile [Presence] in Stool

132

416

1.89

9.89

1.6

1.9

—

(3016244) Insulin [Units/volume] in Serum or Plasma

369

1516

1.45

9.88

3.6

3.3

26.44

26.54

mu/l

0.02

352

1420

(3035320) C reactive protein [Mass/volume] in Body fluid

445

1893

1.40

9.86

2.9

2.5

24.47

29.13

mg/l

1.70

321

1359

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

124

384

1.93

9.78

2.0

1.9

—

(3006270) Folate [Moles/volume] in Blood

446

1902

1.40

9.75

1.2

353.07

373.37

nmol/l

1.27

386

1603

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

849

3984

1.27

9.68

1.1

123.07

115.89

8.05

771

3635

(3028433) Virus identified in Specimen by Culture

202

728

1.66

9.67

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

428

1.87

9.66

1.2

1.3

1.18

mmol/l

0.24

134

428

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

206

2.29

9.65

1.2

1.1

1.65

3.50

umol/24h

0.53

206

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

3.75

9.63

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1077

5199

1.24

9.63

3.0

3.7

708.96

1016.54

u/ml

0.63

981

4703

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

207

752

1.64

9.61

2.6

2.5

134.47

137.06

au/ml

0.03

103

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

214

785

1.63

9.57

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4069

21854

1.12

9.54

1.4

1.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

118

363

1.94

9.51

1.5

1.8

1.18

mmol/l

0.12

111

347

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

434

1852

1.40

9.47

1.8

1.7

3.58

3.83

mg/l

0.66

417

1770

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

199

719

1.65

9.45

1.3

21.08

23.86

0.21

125

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

196

707

1.65

9.37

2.6

3.3

1.82

1.80

ratio

0.06

179

649

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1011

4870

1.24

9.24

3.1

3.5

8.64

9.55

pmol/l

1.69

1011

4864

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

375

1567

1.43

9.22

1.1

1.2

1.05

1.06

ratio

1.56

311

1319

(3020123) Porphyrins [Interpretation] in Serum or Plasma

116

2.72

9.22

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

229

863

1.58

9.20

3.0

3.4

7.42

8.81

mg/l

2.17

181

701

(3047189) Immunofixation for 24 hour Urine

251

968

1.55

9.14

1.6

1.8

—

(3020491) Glucose [Moles/volume] in Blood

428

1834

1.39

9.14

1.9

1.8

7.00

6.74

mmol/l

0.94

330

1317

(3003888) Timothy IgE Ab [Units/volume] in Serum

1063

5156

1.23

9.12

1.1

3.64

4.75

u/ml

2.14

538

2703

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

200

2.27

9.12

1.4

1.3

16.11

14.61

pmol/l

0.07

166

(4198724) Urine methamphetamine measurement

286

1136

1.50

9.10

3.7

2.0

—

(37021550) Renin [Units/volume] in Plasma --upright

136

446

1.82

9.07

1.3

55.42

70.53

mu/l

0.54

102

346

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

131

2.59

9.06

1.1

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

3.64

9.01

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

534

2377

1.34

9.00

1.1

—

75.00

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

424

1819

1.39

9.00

1.7

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

306

1237

1.48

8.95

2.3

1.8

144.16

149.41

0.49

282

1178

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

863

4099

1.26

8.94

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

756

3535

1.28

8.92

1.3

7.23

7.09

mmol/l

0.62

670

3108

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

176

2.34

8.88

1.1

1.2

1.80

1.76

iu/ml

0.07

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

217

817

1.59

8.78

1.1

94.76

87.23

3.42

107

409

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

263

1038

1.51

8.65

2.1

105.03

114.20

ug/min

0.09

242

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

576

2610

1.32

8.62

1.2

59.29

62.71

u/l

0.58

506

2304

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

349

1459

1.43

8.60

1.2

1.3

85.61

97.19

u/l

1.18

289

1257

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

412

1774

1.39

8.58

1.4

1.5

—

(37208534) Antinuclear antibody arbitrary concentration in serum

218

827

1.57

8.56

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

210

791

1.58

8.50

1.1

1.2

99.67

86.37

5.35

106

394

(3018133) Calcium [Moles/volume] in Urine

122

395

1.84

8.50

1.7

1.6

2.79

2.83

mmol/l

0.07

110

362

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

129

2.54

8.43

1.0

1.1

2.89

3.36

u/l

—

(3030313) Adrenal Ab [Titer] in Serum

204

2.19

8.37

1.0

1.1

22.00

47.00

titre

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

144

2.44

8.36

1.2

1.1

167.86

49.39

u/l

0.50

117

(3010015) Selenium [Moles/volume] in Serum or Plasma

228

2.12

8.32

1.9

1.7

1.33

1.37

umol/l

0.52

156

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1014

4950

1.22

8.24

1.1

1.07

1.04

u/ml

0.03

440

2107

(3042631) Mycobacterium sp identified in Specimen

669

3114

1.28

8.22

2.7

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

630

2920

1.29

8.02

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

3.27

8.01

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5402

29695

1.09

7.99

2.1

2.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

796

3799

1.25

7.97

1.1

2.38

2.97

eliau/ml

1.14

351

1956

(1175426) CD3 cells/Lymphocytes in Blood

429

1884

1.36

7.96

2.2

2.0

73.84

72.82

0.78

403

1818

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

393

1702

1.38

7.95

2.3

2.6

0.73

0.69

e9/l

0.48

376

1638

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

167

606

1.64

7.89

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

308

1280

1.44

7.88

1.8

1.9

7.65

8.34

mmol/l

2.78

308

1280

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

278

1.97

7.88

1.5

1.3

52.68

52.36

0.02

140

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

337

1426

1.41

7.82

1.2

1.3

24.66

26.75

u/l

0.26

279

1210

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

102

321

1.90

7.79

1.2

0.30

0.29

nmol/l

0.12

216

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

215

834

1.54

7.72

1.1

1.2

114.11

105.85

2.21

186

773

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

870

4216

1.23

7.62

1.2

1.3

3.50

3.87

u/ml

0.44

386

2032

(3036048) Francisella tularensis Ab [Titer] in Serum

159

576

1.65

7.58

1.2

470.00

574.67

titre

0.10

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

263

1069

1.47

7.58

1.1

98.66

96.71

0.47

208

853

(4211845) Urine protein measurement

286

1183

1.44

7.53

3.1

2.8

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

356

1.83

7.45

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

520

2374

1.31

7.45

3.6

3.4

14.89

13.86

index

0.58

278

1420

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

772

0.49

7.40

7.4

6.9

8.55

8.68

0.07

772

(40761995) Spermatozoa Progressive [#/volume] in Semen

772

0.49

7.40

3.7

3.4

40.00

45.60

1.23

772

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

685

3243

1.26

7.39

1.7

2.0

6428.24

3672.31

titre

0.30

156

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

259

1058

1.46

7.30

1.1

7.69

8.83

u/ml

0.16

185

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2612

13895

1.13

7.26

3.0

3.6

45.44

55.88

u/ml

1.26

2512

13480

(3052592) Norovirus Ag [Presence] in Stool

125

430

1.73

7.22

1.2

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

514

2354

1.30

7.22

4.4

5.6

195.11

85.20

u/ml

1.47

153

829

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

612

1.61

7.20

1.0

1.1

—

(4133840) Spirometry

185

706

1.56

7.17

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

107

352

1.81

7.17

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

895

0.54

7.10

1.7

1.4

0.52

e9/l

0.03

895

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

259

1065

1.45

7.07

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

259

1066

1.45

7.04

1.3

1.4

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.80

7.01

1.1

0.04

0.63

mg/l

0.52

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

407

1812

1.34

6.98

2.2

1.9

15.57

15.15

0.36

392

1762

(21491868) Cryoglobulin [Mass/volume] in Serum

216

859

1.50

6.97

1.2

0.41

0.55

g/l

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

883

4329

1.22

6.96

1.2

1.3

2.49

3.89

u/ml

2.24

310

1704

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

286

1202

1.42

6.95

1.3

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.94

6.82

1.0

1.1

4.66

5.26

mmol/l

0.48

(3000060) B lymphocytes [#/volume] in Blood

182

701

1.55

6.81

2.1

1.8

0.19

1.30

e9/l

1.38

288

(3036603) Volume of Urine

434

1959

1.32

6.79

1.7

1.6

2023.71

2014.09

0.07

420

1922

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

117

1152

0.60

6.70

2.2

2.7

134.49

151.82

nmol/l

0.99

107

1021

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

209

833

1.50

6.69

2.8

3.0

28.56

28.93

umol/l

0.17

162

637

(3006462) Nitrate [Presence] in Urine

261

1087

1.43

6.69

3.3

2.9

—

(21494434) Karyotype in Bone marrow

458

2088

1.31

6.69

1.2

—

(1616796) Gas panel - Central venous blood

1129

5692

1.19

6.62

3.3

3.6

—

(40765089) Chromosome analysis panel - Blood by G-banded

981

0.58

6.57

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

112

386

1.73

6.48

1.6

1.9

1.19

mmol/l

0.39

106

367

(3006922) Hepatitis E virus Ab [Presence] in Serum

466

2142

1.30

6.43

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

341

1498

1.36

6.42

2.7

2.8

41.20

38.73

1.57

225

735

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

127

2.30

6.22

1.7

1.5

10.78

15.09

0.63

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

186

2.05

6.18

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

228

1.94

6.11

1.0

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

187

2.04

6.10

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

348

1547

1.34

6.10

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

872

4336

1.20

6.01

1.1

48.94

1113.30

iu/ml

1.61

173

862

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1729

9080

1.14

5.97

1.3

209.38

226.19

miu/ml

1.11

773

4195

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

249

1052

1.41

5.96

3.9

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

635

3061

1.24

5.96

1.1

100.16

96.64

2.75

599

2878

(3013247) Albumin in CSF/Albumin in Serum or Plasma

145

548

1.58

5.95

1.1

7.54

6.63

mg/g

0.65

137

525

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

246

1039

1.41

5.90

2.2

2.5

50.86

51.68

umol/l

0.13

207

909

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

438

2026

1.29

5.81

1.9

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

192

1646

0.69

5.74

1.3

1.8

334.24

838.05

pmol/l

0.49

230

(3037692) Legionella sp identified in Specimen by Organism specific culture

201

822

1.46

5.74

1.6

1.4

—

(3036180) Methadone [Presence] in Urine

3.58

5.68

3.5

3.3

—

(3010503) CD19 cells [#/volume] in Blood

334

1495

1.33

5.63

2.4

2.6

302.49

364.99

e6/l

0.19

319

1462

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

322

1.74

5.62

1.4

1.5

8.82

240762.29

nmol/l

1.76

265

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

303

1337

1.35

5.62

1.3

1.4

5.81

5.62

mmol/l

1.87

287

1257

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

210

872

1.44

5.56

1.8

1.7

47239.05

10992.40

u/ml

0.69

116

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

335

1504

1.33

5.54

3.0

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

862

0.59

5.40

2.5

3.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

287

1.77

5.35

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

270

2163

0.74

5.35

1.5

1.6

8.40

7.68

mmol/l

4.17

259

2070

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.42

5.30

1.1

273.81

591.18

u/l

1.15

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5826

32647

1.07

5.29

2.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

145

2.10

5.27

1.1

1.2

0.68

0.56

iu/ml

0.15

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

343

1559

1.31

5.24

1.8

2.0

103.92

97.20

2.54

308

1480

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

265

1159

1.36

5.23

1.1

1.2

32.85

9.41

u/ml

0.63

128

(3010421) pH of Blood

1475

7742

1.14

5.19

3.4

3.5

7.41

0.62

1452

7622

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

146

2.08

5.18

1.8

1.5

36.80

39.61

0.16

100

(3017569) Oxygen content in Arterial blood

288

1279

1.34

5.16

1.9

2.2

16.22

15.85

1.00

288

1279

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

195

811

1.43

5.16

2.3

2.5

0.79

1.08

ug/l

1.94

185

768

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2897

15799

1.10

5.15

2.0

—

(4281824) Cell count and differential, peritoneal fluid

403

3044

0.79

5.13

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

116

433

1.60

5.08

1.7

1.6

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.34

5.05

1.5

1.4

0.15

0.19

u/l

0.06

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

284

1.74

5.03

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

189

786

1.43

5.01

1.1

2.00

3.66

u/ml

0.94

(3021661) Pineapple IgE Ab [Units/volume] in Serum

3.75

4.91

1.1

1.0

0.14

0.12

u/ml

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

110

2.22

4.89

1.5

1.6

0.71

0.73

umol/l

0.05

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

276

1231

1.34

4.84

1.7

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

276

1231

1.34

4.84

1.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

276

1231

1.34

4.84

1.7

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

871

4422

1.18

4.84

1.1

3.44

3.58

u/ml

0.09

439

2145

(3027315) Oxygen [Partial pressure] in Blood

1000

5137

1.16

4.80

3.8

3.9

8.71

8.65

kpa

0.52

976

5009

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1241

6478

1.14

4.78

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

275

1229

1.34

4.77

1.7

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

960

4920

1.17

4.75

1.1

1.20

1.66

u/ml

1.25

496

2345

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

108

2.21

4.71

1.6

1.3

1.15

1.26

0.07

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.34

4.71

1.1

2.09

1.19

u/ml

0.21

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

629

3113

1.21

4.67

1.9

2.0

30.53

25.14

ug/l

0.53

617

3056

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1046

5405

1.16

4.66

1.6

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

399

1883

1.26

4.62

1.1

20.84

18.72

u/ml

0.32

136

836

(3050794) Legionella sp Ab [Presence] in Serum

204

1.84

4.60

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

102

379

1.60

4.60

1.7

1.9

39.98

58.99

pmol/l

0.76

316

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

329

1.65

4.57

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.14

4.53

1.9

3.3

1.22

2.89

mu/l

1.45

(40767503) Oxygen content in Capillary blood by calculation

1000

5162

1.16

4.53

2.7

2.6

16.82

16.55

1.92

981

5037

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

298

1.68

4.52

1.2

1.3

6.22

5.78

mmol/l

2.06

298

(3012501) Base excess in Blood by calculation

990

5109

1.16

4.50

3.7

3.9

2.27

2.52

mmol/l

2.30

677

3408

(3048929) Epstein Barr virus Ab [Presence] in Serum

1600

8523

1.12

4.50

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

730

3677

1.19

4.49

1.9

1.8

1.68

1.76

mmol/l

1.12

711

3570

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1513

8034

1.13

4.49

2.5

2.4

185.34

190.77

1.51

1416

7663

(3013290) Carbon dioxide [Partial pressure] in Blood

990

5111

1.16

4.48

3.7

3.9

5.00

4.98

kpa

0.42

966

4983

(3000093) Morphology [Interpretation] in Blood Narrative

492

2389

1.23

4.44

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

437

2095

1.24

4.44

1.4

1.3

165.22

188.35

pmol/l

1.04

437

2095

(3023430) Cat dander IgE Ab [Units/volume] in Serum

823

4200

1.17

4.34

1.1

4.34

4.24

u/ml

0.04

368

1853

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

170

1.89

4.31

1.1

7.83

10.56

u/l

0.65

170

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

5.17

4.31

1.2

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

251

1127

1.33

4.27

3.9

5.0

1560.03

2662.61

mg/l

0.42

177

802

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

846

4334

1.17

4.26

2.6

2.8

16849.36

6294.91

u/ml

0.37

230

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1315

6948

1.13

4.26

1.2

1.3

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.91

4.25

1.0

2.19

3.19

0.56

(3003694) ABO and Rh group [Type] in Blood

13716

79162

1.04

4.18

1.4

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

204

891

1.37

4.16

1.4

593.86

679.05

mu/l

0.19

195

844

(3008037) Lactate [Moles/volume] in Venous blood

1152

6045

1.14

4.16

3.4

3.0

1.54

1.60

mmol/l

1.71

1121

5920

(3008116) Ketones [Moles/volume] in Urine by Test strip

136

553

1.47

4.14

1.6

1.4

0.30

0.23

mmol/l

0.26

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

152

1.92

4.10

1.0

1.1

3.68

0.89

u/ml

0.35

143

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

206

905

1.36

4.07

1.4

73.25

72.67

0.22

197

858

(3001218) Citrate [Mass/time] in 24 hour Urine

2.98

4.00

1.8

1.3

403.89

392.74

mg/24h

0.06

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

277

1.66

3.99

1.0

1.1

—

(4268621) Lupus anticoagulant assay

603

3022

1.19

3.98

2.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

3.07

3.96

1.0

365.44

347.63

umol/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

171

1.85

3.96

1.6

3.04

1.69

mg/l

0.74

115

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

347

1.58

3.96

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

147

613

1.43

3.94

1.1

1.11

1.68

u/ml

0.48

343

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

4.56

3.92

1.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

185

1.80

3.90

1.2

1.1

97.14

97.38

titre

0.01

185

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

155

1.88

3.89

1.0

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

611

4294

0.85

3.88

3.5

3.7

39.90

39.52

u/ml

0.02

594

4136

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

164

1.85

3.86

6.6

5.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

169

1.83

3.82

1.6

2.56

1.61

mg/l

0.58

104

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

169

1.83

3.82

1.6

2.03

1.81

mg/l

0.14

124

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

148

1.89

3.79

1.1

15.66

14.43

nmol/l

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1612

8683

1.11

3.78

2.1

95.30

92.62

5.05

1540

8364

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.07

3.76

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

118

477

1.48

3.74

1.1

1.0

1.14

1.26

u/ml

0.06

425

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

235

1069

1.31

3.71

3.2

3.4

1.50

1.26

1.03

235

1069

(3001686) Cold agglutinin [Titer] in Serum or Plasma

102

401

1.52

3.69

1.2

1.3

242.89

379.18

titre

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

150

1.87

3.66

1.5

309.47

310.28

umol/24h

0.01

150

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

446

2197

1.21

3.59

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

318

1511

1.26

3.59

1.1

1.2

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

1.30

1.33

mg/l

0.01

106

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

0.82

0.83

mg/l

0.01

114

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

3.43

3.29

mg/l

0.05

104

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

2.41

2.36

mg/l

0.02

124

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

4.12

2.07

mg/l

1.17

118

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

2.98

2.15

mg/l

0.39

121

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

169

1.80

3.55

1.6

3.38

1.83

mg/l

0.66

114

(40768795) Lymph node Pathology biopsy report

379

2753

0.82

3.51

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

204

0.35

3.49

1.0

1.1

1.34

1.29

mom

0.06

204

(44806420) Estimation of glomerular filtration rate

469

3334

0.84

3.46

2.7

2.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

327

1.55

3.42

1.4

1.3

546.87

170.75

u/l

0.38

230

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

141

1.86

3.41

1.0

1.4

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

361

1.52

3.40

1.5

1.6

106.38

112.16

ug/l

0.20

296

(1617658) Protocol used for examination of sentinel lymph nodes

267

2004

0.79

3.38

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

107

434

1.47

3.38

1.6

1.7

1.18

1.17

nmol/l

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

198

894

1.32

3.34

1.9

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

198

895

1.32

3.32

1.9

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

724

3746

1.15

3.30

1.0

1.1

0.30

0.41

u/ml

0.43

254

1083

(3002621) Streptococcal DNAse B [Units/volume] in Serum

183

1.73

3.25

1.1

187.90

461.89

u/ml

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

5.36

3.21

1.0

44.33

19.30

umol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

297

1424

1.24

3.15

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

360

1.49

3.08

1.1

1.0

0.43

0.20

u/ml

0.33

226

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

198

906

1.30

3.07

1.9

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

117

1.89

3.02

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

285

1.55

3.01

1.5

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

271

1.56

3.00

1.8

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

419

2092

1.20

3.00

1.2

192.91

197.03

titre

0.03

333

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1120

6000

1.11

2.99

1.4

128.32

135.95

pmol/l

0.22

1088

5862

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

248

1.59

2.98

1.0

1.1

1.13

7.05

u/ml

0.43

130

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

354

1.48

2.94

1.2

1.3

37.82

42.16

mg/l

0.40

296

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

306

1.52

2.94

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

167

1.71

2.91

1.6

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

169

1313

0.77

2.90

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

296

1435

1.23

2.88

1.2

1.1

20.18

24.36

u/l

0.96

270

1278

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

298

1446

1.23

2.87

1.2

1.1

78.30

85.55

u/l

1.02

271

1290

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

256

1.56

2.84

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.88

2.84

1.1

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

416

2088

1.19

2.84

1.2

212.86

161.97

titre

—

(3022806) Fractional oxyhemoglobin in Capillary blood

547

2810

1.16

2.81

1.8

90.42

89.68

2.80

535

2769

(3001964) Herpes simplex virus Ag [Presence] in Specimen

155

695

1.33

2.81

1.6

1.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

134

588

1.36

2.80

1.2

10.66

12.41

pmol/l

0.45

221

(4035726) Immunohistochemistry procedure

3723

23408

0.94

2.79

1.4

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

3.25

2.72

1.1

4275.50

3702.45

titre

0.24

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

144

1.74

2.70

1.4

1.7

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

153

1.71

2.69

1.1

1.2

17.67

24.61

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

145

1136

0.76

2.68

1.2

1.3

1058.82

1009.96

titre

0.20

251

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

137

608

1.34

2.68

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1961

10850

1.08

2.66

2.4

2.3

5791.13

5717.97

u/l

0.03

660

4526

(3025549) Creatine [Moles/time] in 24 hour Urine

186

1.63

2.63

1.5

1.3

—

11.64

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

110

1.84

2.63

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

102

433

1.40

2.62

2.3

2.5

7.43

7.51

mmol/l

0.07

258

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

613

3198

1.14

2.58

1.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

747

3950

1.13

2.56

1.9

2.4

4.71

9.28

titre

0.96

127

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

5.21

2.55

1.9

1.0

0.02

0.03

mg/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

298

1.48

2.52

1.6

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

157

1.67

2.48

2.1

2.2

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

270

1.50

2.48

1.5

1.4

73.41

71.28

0.22

228

(3042628) Porphyrins [Moles/volume] in Urine

5.96

2.43

1.3

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.12

2.43

1.0

0.03

0.06

u/ml

0.73

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.36

2.43

1.1

1.0

0.03

0.14

u/ml

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

131

1.73

2.43

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

126

562

1.34

2.42

1.1

24.52

29.41

iu/ml

0.63

126

562

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

380

1.41

2.41

1.0

93.21

80.60

ug/l

1.72

304

(3007463) Buprenorphine [Presence] in Urine

105

1.82

2.40

8.1

7.6

—

(40759632) Porphyrins [Mass/mass] in Stool

3.31

2.39

1.0

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.48

2.38

1.1

1.0

1.25

0.49

u/ml

0.35

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

190

900

1.26

2.35

2.6

1.8

162.84

169.97

0.39

178

850

(37019676) Renin [Units/volume] in Plasma --supine

2.38

2.34

1.1

1.0

65.35

74.25

mu/l

0.06

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

1465

1.20

2.34

1.5

7.36

6.92

u/l

0.23

235

1154

(3041672) Baker's yeast Ab [Presence] in Serum

106

1.80

2.34

1.0

—

(3024316) Viscosity of Plasma

106

1.80

2.34

2.0

1.7

1.72

1.63

mpas

0.25

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

124

1.73

2.32

1.0

17.11

25.28

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

124

1.73

2.32

1.0

19.40

17.75

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

280

1998

0.83

2.30

1.2

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.96

2.25

1.0

1.1

160.82

247.08

pmol/l

0.85

(3033942) Copper [Moles/time] in 24 hour Urine

1.81

2.23

1.1

1.2

0.33

0.63

umol/24h

0.50

(3000285) Sodium [Moles/volume] in Blood

100

437

1.36

2.22

1.2

138.62

138.47

mmol/l

0.12

386

(3041918) Cholesterol [Moles/volume] in Pleural fluid

105

463

1.35

2.21

1.3

1.2

1.66

1.63

mmol/l

0.05

285

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

3.67

2.19

1.0

—

(3027874) Urate [Moles/volume] in Urine

1.91

2.19

1.2

1.1

1.31

9.60

mmol/l

0.52

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

373

1.39

2.18

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

279

1.45

2.16

2.8

2.1

1.02

1.09

mmol/l

0.11

187

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

287

1435

1.19

2.14

1.5

1982222.41

1930326.31

iu/ml

0.03

(3012989) Citrate [Moles/time] in 24 hour Urine

2.15

2.12

1.6

2.02

1.88

mmol/24h

0.23

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

110

1.73

2.10

1.8

1.5

408.18

482.55

nmol/l

0.49

110

(3021162) Amylase [Enzymatic activity/volume] in Specimen

427

1.35

2.08

2.6

2.8

953.75

1584.64

u/l

0.55

381

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

1246

0.80

2.08

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

107

479

1.33

2.06

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

272

1.45

2.06

1.2

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

228

1.49

2.06

1.1

1.3

715.79

304.30

mg/24h

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.79

2.03

1.1

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.79

2.03

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

273

1367

1.19

2.03

4.9

7.5

62.08

3561.58

u/ml

0.95

298

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

200

1.52

2.03

1.2

78.77

112.32

ug/l

1.29

120

(3016031) Almond IgE Ab [Units/volume] in Serum

162

1.58

2.03

1.0

0.16

0.44

u/ml

0.99

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

293

1.42

2.02

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

180

865

1.24

2.02

1.1

1.0

6.73

10.20

u/ml

1.61

114

571

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

311

1579

1.17

1.98

1.7

1.9

—

(3023383) Lactate [Moles/volume] in Pleural fluid

153

724

1.26

1.97

1.5

1.3

3.40

3.41

mmol/l

0.01

138

673

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.37

1.97

2.5

2.0

274.00

254.46

ug/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

382

1.36

1.93

2.6

2.7

—

(3051101) Glucose [Moles/volume] in Cord blood

457

0.69

1.91

4.8

5.8

8.73

8.52

mmol/l

0.08

457

(3008536) Aspergillus sp Ab [Presence] in Serum

110

502

1.31

1.89

1.8

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

131

612

1.28

1.89

1.7

1.9

17.31

36.31

u/l

2.98

120

554

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.99

1.88

1.2

34.62

34.45

mg/24h

0.01

(3007542) Rye IgE Ab [Units/volume] in Serum

138

1.60

1.84

1.0

1.1

0.17

14.08

u/ml

0.52

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

208

1028

1.21

1.82

1.9

—

(3013466) aPTT in Blood by Coagulation assay

148

1.57

1.81

1.1

36.25

38.12

0.66

130

(3014148) Varicella zoster virus Ab [Titer] in Serum

704

3798

1.11

1.81

1.1

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1507

8398

1.07

1.80

2.6

2.5

3.57

3.61

g/l

0.60

1426

8056

(4038314) Semen analysis, post vasectomy

212

0.56

1.79

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

496

3315

0.89

1.76

2.3

2.5

24.54

27.10

iu/ml

0.21

307

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.21

1.75

1.3

1.2

34.29

31.77

nmol/24h

—

(36304079) Mucus [Presence] in Urine sediment

3.58

1.71

1.2

1.0

—

(3051651) Icteric interference index of Serum or Plasma

284

1454

1.16

1.68

3.9

3.8

0.83

0.91

index

0.62

277

1420

(40768806) Pleura Pathology biopsy report

408

2750

0.88

1.68

1.6

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

466

3115

0.89

1.67

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

373

1.33

1.63

1.5

1.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

316

1637

1.15

1.62

11.9

13.6

0.59

0.63

mmol/l

2.19

294

1500

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

129

1.57

1.61

1.1

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

400

1.31

1.60

1.1

0.89

1.30

u/ml

0.24

253

(43055514) Macroprolactin [Presence] in Serum or Plasma

143

691

1.23

1.60

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

390

1.31

1.60

1.4

1.2

0.87

1.21

mmol/l

0.43

243

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.66

1.58

1.1

280.89

258.16

nmol/l

0.24

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

258

1319

1.17

1.58

1.9

1.7

2.02

2.91

u/field

0.97

187

957

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

556

0.75

1.58

1.6

2.0

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

229

1.41

1.53

1.0

1.1

4.65

0.49

u/ml

0.44

114

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

617

3341

1.10

1.53

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

372

1959

1.13

1.52

1.4

12.87

12.32

umol/l

0.71

350

1850

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

447

2381

1.12

1.51

1.3

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

245

1.39

1.50

1.0

0.09

u/ml

0.02

120

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

177

882

1.20

1.48

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

318

1.33

1.46

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

868

4786

1.08

1.45

1.5

0.31

0.42

nmol/l

5.73

655

3721

(3011841) English Walnut IgE Ab [Units/volume] in Serum

207

1.41

1.43

1.0

0.09

1.22

u/ml

1.28

156

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.61

1.42

1.0

1.1

1.03

0.80

u/ml

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.99

1.42

1.0

3.78

1.02

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1012

5618

1.07

1.42

1.2

38.66

49.59

u/ml

0.44

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

248

1.37

1.41

1.0

0.18

0.45

u/ml

0.48

121

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

173

1.45

1.41

1.5

3.8

1.21

93.94

pmol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

110

1.57

1.41

26.4

13.0

104.34

106.69

g/l

0.45

110

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

301

1573

1.14

1.40

6.1

7.4

32.53

58.68

ug/l

0.56

192

1045

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.31

1.40

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

336

1770

1.13

1.39

1.1

1.0

1.10

2.65

u/ml

0.76

115

514

(3010375) cycloSPORINE [Mass/volume] in Blood

216

1103

1.17

1.38

31.9

29.4

125.86

114.81

ug/l

1.29

177

891

(3007700) Barley IgE Ab [Units/volume] in Serum

125

1.53

1.38

1.0

0.97

11.11

u/ml

0.46

(3011335) Digoxin [Mass/volume] in Serum or Plasma

164

1.45

1.38

2.5

2.2

0.59

0.68

ug/l

1.02

164

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.79

1.37

1.0

1.3

107.38

33.32

umol/24h

0.43

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.62

1.37

3.8

4.1

—

(40768800) Prostate Pathology biopsy report

812

5223

0.93

1.37

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3374

19386

1.04

1.35

2.2

2.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

261

1.35

1.34

1.7

2.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

110

529

1.24

1.34

1.1

—

(3014891) Appearance of Pleural fluid

357

0.72

1.34

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

949

5273

1.07

1.32

1.2

1.3

271.81

260.10

u/ml

0.55

624

3439

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.83

1.32

1.0

0.24

0.66

u/ml

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

110

530

1.24

1.32

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

474

2557

1.11

1.31

1.3

1.4

8.84

8.52

mmol/l

0.86

453

2433

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

110

531

1.23

1.30

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.41

1.29

1.4

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.78

1.28

1.1

0.10

0.07

u/ml

0.18

(3018001) Oat IgE Ab [Units/volume] in Serum

182

1.41

1.27

1.0

0.09

0.82

u/ml

0.73

108

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

238

1.35

1.27

1.0

0.02

0.36

u/ml

1.37

147

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

110

533

1.23

1.26

1.1

1.2

103.22

84.86

1.96

171

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1793

10176

1.05

1.26

1.8

1.7

4.56

4.08

mg/l

0.85

1412

7360

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

998

5572

1.07

1.23

1.3

1.4

17.72

22.06

u/ml

0.32

113

(3036312) Salmon IgE Ab [Units/volume] in Serum

144

1.45

1.21

1.0

1.1

0.76

1.07

u/ml

0.20

(3001019) Free T4 and TSH panel - Serum or Plasma

2441

15138

0.96

1.21

1.7

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

308

1.30

1.20

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.17

1.18

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1669

9481

1.05

1.16

1.3

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

117

579

1.20

1.13

1.3

115.14

104.86

2.59

111

552

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

999

5601

1.06

1.12

1.4

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

705

3906

1.08

1.11

4.6

5.6

343.92

367.05

umol/l

4.26

614

3431

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.61

1.11

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

209

1.34

1.08

1.0

0.24

1.60

u/ml

0.73

157

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

335

1.26

1.07

1.6

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

462

2522

1.09

1.06

1.4

1.3

6.37

6.22

mmol/l

0.57

428

2352

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

109

540

1.20

1.06

1.1

79.24

76.24

0.24

168

(3013945) Hepatitis B virus e Ab [Presence] in Serum

174

1.37

1.05

1.9

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

169

1.38

1.05

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

164

1.38

1.05

7.0

4.8

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

149

1.40

1.04

1.0

3.74

2.11

u/ml

0.17

116

(3000012) Reticulocyte production index

621

3437

1.08

1.03

2.0

2.3

0.90

0.06

416

2364

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.83

1.02

1.9

1.3

0.83

0.54

u/field

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

107

0.56

1.02

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

0.68

1.01

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.57

0.98

1.1

1.0

17.58

12.91

mg/l

0.25

(3035880) pH of Pleural fluid

246

1307

1.12

0.98

1.3

7.42

7.40

0.49

169

912

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

344

1862

1.10

0.97

1.5

1.4

12.86

u/l

0.00

331

1804

(3019174) dRVVT (LA screen)

214

1.31

0.95

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

127

1.41

0.94

1.1

—

(3013762) Body weight Measured

0.56

0.91

1.0

1.1

—

(3003577) Lead [Moles/volume] in Blood

242

1.28

0.91

1.4

1.5

0.16

0.34

umol/l

1.19

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

306

1.25

0.90

3.3

3.1

40.51

41.77

umol/l

0.19

266

(3003740) Influenza virus B Ag [Presence] in Specimen

974

5503

1.06

0.90

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.74

0.89

1.1

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

180

1.32

0.89

1.0

1.1

16.40

18.94

iu/ml

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

2.10

0.89

1.0

1.5

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.10

0.89

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

366

1.22

0.88

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

366

1.22

0.88

2.2

1.9

—

(3034426) Prothrombin time (PT)

161

840

1.14

0.88

1.2

27.82

28.23

0.42

161

840

(3002523) Influenza virus A Ag [Presence] in Specimen

973

5504

1.05

0.87

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

145

0.66

0.87

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

137

0.65

0.85

4.2

5.3

—

(3001729) Color of Synovial fluid

167

1.32

0.82

1.4

1.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

246

1.26

0.82

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

203

1081

1.12

0.82

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

152

1.33

0.80

1.4

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

142

1.34

0.80

1.4

1.9

0.52

0.80

0.51

114

(3045142) Bone marrow Pathology biopsy report

504

2804

1.07

0.79

1.3

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.54

0.78

1.1

1.8

—

1493.54

—

(3038515) Glucose [Moles/volume] in Venous blood

909

5153

1.05

0.78

3.7

3.2

7.38

7.64

mmol/l

1.49

879

5057

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.49

0.77

1.0

0.01

0.19

u/ml

0.92

(3033086) Enterovirus Ab [Titer] in Serum

1.47

0.77

1.0

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

344

1890

1.09

0.76

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

197

1054

1.11

0.75

1.5

1.6

4510.24

3361.70

titre

1.15

169

(3034614) HLA Ag [Interpretation]

1.57

0.75

1.3

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.55

0.75

1.0

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

473

1.17

0.74

6.5

7.0

61.84

70.68

2.09

365

(3012898) Urea [Moles/volume] in Urine

266

1.23

0.74

1.3

1.6

168.43

167.65

mmol/l

0.02

229

(4212803) Bone marrow aspirate examination

186

1.28

0.74

1.2

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

181

1.28

0.73

1.6

1.5

14.42

16.17

pmol/l

0.36

159

(3045788) Cell count panel - Pleural fluid

457

2544

1.07

0.73

1.5

—

(3042733) HLA Ab [Presence] in Serum

145

975

0.89

0.73

4.7

5.1

—

(3044009) aPTT.lupus sensitive (LA screen)

224

1.25

0.72

1.1

1.2

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

124

1.35

0.72

1.0

6.54

17.01

u/ml

1.71

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

338

1.20

0.71

1.5

5.51

5.62

nmol/l

0.06

323

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

431

2398

1.07

0.70

1.4

1.3

410.61

498.89

u/l

0.73

404

2278

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

306

1.21

0.70

2.3

2.6

0.47

0.61

u/field

0.63

306

(3039744) RNA polymerase III Ab [Units/volume] in Serum

204

1.26

0.69

1.0

1.1

8.50

3.07

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

372

1.19

0.69

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

224

1217

1.10

0.66

1.3

1.5

—

(40768446) Kidney Pathology biopsy report

175

1156

0.90

0.66

1.6

1.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

363

2014

1.07

0.66

1.1

1.2

83.17

79.97

0.43

126

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

224

1218

1.10

0.66

1.3

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.70

0.64

1.3

3.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.75

0.63

1.0

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.64

0.63

1.0

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.64

0.63

1.0

1.1

1.63

1.24

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.55

0.63

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

258

1417

1.09

0.62

1.4

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

222

1212

1.09

0.61

1.6

1.7

1.67

2.58

u/ml

0.86

341

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.79

0.59

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

198

1289

0.91

0.58

43.1

42.0

7.57

7.30

ug/l

0.84

178

1167

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.42

0.58

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.54

0.57

1.6

1.3

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.70

0.57

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

902

5162

1.04

0.57

1.4

1.5

158.19

149.04

au/ml

1.42

250

1524

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

183

1.24

0.57

1.1

1.0

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.35

0.56

1.0

9121.00

9798.35

ng/l

—

(40768441) Liver Pathology biopsy report

356

1991

1.07

0.55

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

223

1.20

0.53

1.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

391

2469

0.94

0.53

3.4

4.2

35.21

65.43

u/ml

4.01

382

2447

(46235355) HIV 1 and 2 tests - Meaningful Use set

9143

53901

1.01

0.52

1.9

2.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

473

1.13

0.52

1.6

1.9

10.11

2.87

ug/l

0.51

303

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.37

0.51

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

106

1.29

0.50

1.0

0.29

0.34

u/ml

0.08

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

245

1362

1.07

0.48

1.4

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

127

0.75

0.48

1.2

—

(44786800) Granulocytes/Leukocytes in Body fluid

284

0.84

0.47

1.4

1.3

14.53

24.74

1.44

221

(3003157) Bacteria [#/volume] in Mother's milk

0.57

0.47

2.2

7.6

—

(3004775) Volume in Urine collected for unspecified duration

305

1930

0.94

0.46

2.3

657.93

678.19

0.35

215

1329

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.41

0.46

5.5

5.4

0.42

0.22

mmol/l

1.16

(3018291) Platelet Ab [Presence] in Serum

1.49

0.46

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

340

1915

1.06

0.45

1.3

13.47

13.87

u/l

0.14

301

1766

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

140

1.23

0.45

1.0

0.04

0.20

u/ml

0.93

140

(3016228) CD19 cells/cells in Blood

179

988

1.08

0.44

2.1

2.0

8.29

8.46

0.07

171

970

(3014599) Egg white IgE Ab [Units/volume] in Serum

310

1745

1.06

0.43

1.1

1.0

1.75

1.87

u/ml

0.05

395

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

131

0.77

0.42

1.2

1.1

1.20

1.24

u/field

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.57

0.42

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

621

0.90

0.42

1.3

90.27

54.92

g/l

0.21

475

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1184

7253

0.97

0.42

2.0

1.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

0.74

0.42

1.0

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

470

0.89

0.42

3.2

2.6

55.53

42.60

mg/l

0.27

116

(3012565) Volume of 24 hour Urine

220

1227

1.07

0.41

2.0

2.2

2063.82

1985.62

0.47

203

1107

(3023199) Leukocytes [#/volume] in Pleural fluid

548

3134

1.04

0.41

1.5

2957.85

2866.54

e6/l

0.05

394

2201

(3027974) Hepatitis B virus e Ag [Presence] in Serum

180

1.19

0.41

2.1

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

129

705

1.09

0.41

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

365

1.13

0.40

1.2

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

227

0.84

0.39

1.5

2.2

62.69

58.87

0.18

144

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

109

711

0.91

0.39

1.3

119.67

284.68

ug/l

1.18

378

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.42

0.39

1.6

2.6

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

102

553

1.10

0.39

1.5

1.4

24.06

22.63

0.18

459

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

113

617

1.09

0.37

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

486

2783

1.04

0.37

1.5

1.4

49201.68

54452.54

e6/l

0.12

269

1586

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.28

0.37

1.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

106

1.24

0.36

1.1

1.5

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.72

0.36

1.0

1.1

—

(3024471) HLA-A [Type]

141

905

0.93

0.36

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

117

1.22

0.36

1.1

1.2

2874.08

4951.15

ng/l

0.68

(3000919) Neutrophils/Leukocytes in Pleural fluid

115

631

1.09

0.35

1.6

1.4

26.27

20.03

1.32

104

563

(3044416) Complement C4 [Mass/volume] in Pleural fluid

112

1.22

0.35

1.3

0.06

0.07

g/l

0.34

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

134

1.20

0.35

1.3

—

(46235168) Fasting glucose [Moles/volume] in Blood

341

1.12

0.34

1.3

2.0

5.70

7.43

mmol/l

4.88

118

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

118

1.21

0.34

10.8

9.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

178

0.84

0.33

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

100

0.77

0.33

1.1

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

948

5508

1.03

0.32

4.2

3.1

23.54

28.04

mg/l

3.85

634

3820

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

406

1.10

0.32

1.3

1.4

68.74

99.43

ng/l

0.52

265

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

401

1.10

0.31

1.0

13.40

6.89

u/ml

0.64

401

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.30

0.31

1.0

1.1

2325.71

2176.88

titre

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

359

0.90

0.30

2.5

2.9

63.16

77.76

pmol/l

0.44

310

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

430

1.09

0.30

1.1

1.3

15040.91

224992.50

u/ml

0.47

(3024932) HLA-DR beta [Type]

138

878

0.94

0.30

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.22

0.29

1.2

1.6

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

181

0.86

0.28

1.4

2.1

17.08

18.53

0.07

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.26

0.28

8.6

9.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.31

0.28

1.1

—

(40761536) Microorganisms panel - Urine sediment

3502

21104

0.99

0.28

4.5

3.6

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

406

0.91

0.28

6.0

5.4

38.06

44.78

ug/min

0.56

324

(3016750) Collection duration of Urine

227

1418

0.95

0.27

2.3

2.2

497.39

500.50

min

0.16

173

1070

(40763590) HLA-DQ beta [Type]

103

0.81

0.27

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

169

954

1.06

0.26

2.7

2.9

0.61

mmol/l

0.16

169

954

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

269

1537

1.04

0.26

1.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.25

0.26

2.2

20.82

29.55

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

276

1581

1.04

0.25

1.2

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.35

0.24

2.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

114

0.84

0.23

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

571

1.06

0.22

1.3

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.22

0.0

1.2

—

157.33

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

9.5

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

0.22

0.0

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

312

1.09

0.22

8.1

7.9

0.46

0.41

umol/l

0.18

280

(21494815) CD4 cells/Lymphocytes in Specimen

402

2327

1.03

0.22

2.2

40.07

38.17

1.77

392

2288

(3041184) Isoniazid [Presence] in Urine

1.19

0.21

2.6

3.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.19

0.21

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

112

706

0.95

0.21

1.3

12.48

13.74

g/l

0.71

543

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

108

1.16

0.21

1.0

0.65

0.46

u/ml

0.15

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

540

0.94

0.21

2.5

3.1

90.15

98.07

ng/l

0.12

256

(3035082) Kappa light chains [Mass/volume] in Urine

1.21

0.21

1.1

0.04

g/l

—

(3010937) Rubella virus Ab [Presence] in Serum

175

0.89

0.20

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.19

0.20

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.19

0.20

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.19

0.20

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.19

0.20

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.19

0.20

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.19

0.20

1.0

—

(3025130) Human papilloma virus identified in Specimen

788

4608

1.02

0.20

1.8

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

133

831

0.95

0.19

1.6

1.4

56.63

63.40

1.31

111

675

(40765096) Chromosome analysis panel by Banding

131

744

1.05

0.19

1.2

—

(40760410) HLA-B [Type] by High resolution

105

0.85

0.19

1.0

—

(3013862) HLA-DP [Type]

105

0.85

0.19

1.0

—

(46236302) HLA-C [Type] by High resolution typing

105

0.85

0.19

1.0

—

(40760409) HLA-A [Type] by High resolution

105

0.85

0.19

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

298

0.92

0.19

1.8

2.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1382

8128

1.01

0.18

2.9

3.1

1.56

1.52

mg/l

1.07

1258

7480

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.21

0.18

9.0

9.7

46.00

48.44

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

113

707

0.95

0.18

1.6

1.4

3.30

2.52

0.38

592

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.18

0.17

1.1

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

173

0.90

0.17

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.73

0.17

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

137

851

0.96

0.16

1.8

17647.49

12058.62

e6/l

0.35

426

(3034274) Bile acid [Moles/volume] in Serum --fasting

605

3673

0.98

0.16

1.8

2.2

6.94

6.80

umol/l

0.06

437

2697

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.14

0.16

1.3

1.4

1.00

1.02

u/field

—

(3017509) Phencyclidine [Presence] in Urine

319

1.06

0.14

1.9

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

152

1.10

0.14

1.5

24.33

22.32

mmol/l

1.43

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.17

0.13

1.0

1.35

2.10

u/ml

0.29

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

257

1.07

0.13

1.3

1.2

0.28

0.29

u/ml

0.01

(3006969) Lambda light chains [Mass/volume] in Urine

1.16

0.13

1.1

0.01

0.06

g/l

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.12

0.12

1.0

0.36

1.01

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

502

2947

1.02

0.11

1.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

279

1629

1.02

0.11

1.1

1.0

0.69

0.63

u/ml

0.07

348

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

143

1.08

0.10

2.8

3.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

356

0.95

0.10

1.1

1.2

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

208

1.06

0.09

1.2

1.3

0.99

1.55

ml/s/173m2

0.71

133

(3020393) Adenovirus Ag [Presence] in Stool

214

1.06

0.09

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

135

786

1.02

0.08

2.1

2.0

1.95

1.70

ratio

0.78

126

763

(3020356) Listeria sp identified in Specimen by Organism specific culture

177

0.94

0.07

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.82

0.07

2.1

4.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

225

0.95

0.07

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

168

983

1.02

0.07

1.8

1.9

7370.66

2124.26

e6/l

0.73

116

641

(3039443) Prostate specific Ag panel - Serum or Plasma

805

4764

1.01

0.06

1.6

—

20.32

—

(3020650) Glucose [Presence] in Urine

156

945

0.98

0.05

1.6

1.4

0.00

0.04

estimate

3.52

156

945

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

127

0.94

0.05

1.1

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

365

1.03

0.05

1.6

1.4

7.83

13.62

1.44

183

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

348

2054

1.01

0.05

2.2

1.9

1.64

3.14

u/field

0.73

205

1156

(3044007) Cell count panel - Peritoneal fluid

137

829

0.98

0.04

1.7

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

1005

5967

1.00

0.03

4.9

3.7

—

(40758292) HTLV I+II Ab panel - Serum

497

0.98

0.03

1.3

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1641

9799

1.00

0.02

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

175

1034

1.01

0.02

1.1

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

292

0.98

0.02

2.3

23.10

24.13

mg/l

0.26

280

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

256

0.98

0.02

2.8

2.9

1.39

1.21

mg/l

0.41

166

(3022475) Manganese [Moles/volume] in Blood

154

0.97

0.02

1.2

0.14

0.16

umol/l

1.09

154

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

147

0.97

0.01

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

163

1.02

0.00

1.0

1.1

3.19

6.89

u/ml

1.18

(3001556) Androgen free Index in Serum or Plasma

260

0.99

0.00

1.4

1.3

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

187

1.02

0.00

1.1

1.0

0.39

0.74

u/ml

0.29

132

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.99

0.00

1.2

1.1

—

mmol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

110

0.98

0.00

1.1

—

(40758358) Immune stain study

110

0.98

0.00

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

157

0.99

0.00

1.0

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

133

0.99

0.00

1.1

1.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

133

0.99

0.00

6.8

10.7

88.86

373.75

e6/l

1.31

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

260

1.01

0.00

2.4

2.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

123

1.02

0.00

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7703

45901

1.00

0.00

1.6

1.7

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

320

1.01

0.00

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

207

1.01

0.00

1.6

1.2

59.02

45.77

mg/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

267

1.00

0.00

1.1

21.62

20.51

u/l

0.16

176

(3003434) Protein [Mass/volume] in Pleural fluid

595

3545

1.00

0.00

1.5

1.4

32.52

41.58

g/l

0.53

551

3200

(3047185) IgG [Mass/volume] in Urine

0.91

-0.00

1.0

1.1

—

42.58

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.90

-0.00

1.4

2.1

49.63

11.09

ng/l

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

923.80

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

198.80

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.97

-0.00

4.3

7.2

62.00

3057.59

e6/l

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

3.98

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_INTERVERTEB and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_INTERVERTEB	0.96 [0.88, 1.04]	0.338
Birth year	0.996 [0.99, 1.0]	0.357

During the follow-up period (1.1.1998 — 31.12.2019), 12770 out of 139800 females with M13_INTERVERTEB died.

Males

Parameter	HR [95% CI]	p-value
M13_INTERVERTEB	1.019 [0.94, 1.1]	0.655
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 15026 out of 129744 males with M13_INTERVERTEB died.

Mortality risk

Mortality risk for people of age

years, who have M13_INTERVERTEB.

N-year risk	Females	Males
1	0.11%	0.167%
5	0.548%	1.074%
10	1.392%	2.659%
15	2.709%	4.964%
20	4.762%	8.401%

Relationships between endpoints

↥

Index endpoint: M13_INTERVERTEB – Other intervertebral disc disorders

GWS hits: 70

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other intervertebral disc disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints